Curable polymer composition
By developing a dual network polymer composition containing multiple photopolymer groups and thermally reactive compounds, the safety and biocompatibility of existing photocured materials in live contact is solved, and biodegradable is achieved and controllable preparation of medical materials.
Patent Information
- Application Number
- CN202411134645.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2019-10-09
- Filing Date
- 2020-10-08
- Publication Date
- 2024-12-06
AI Technical Summary
Existing photocuring and thermocuring materials have safety and biocompatibility problems when in contact with live bodies, especially their cytotoxicity is difficult to meet the needs of medical applications.
A curable polymer composition has been developed, which comprises a mixture of multiple photopolymerized groups and thermally reactive compounds, to form a dual network structure through photopolymerization and thermal polymerization, combining photoinitiators and stabilizers, using in the preparation of biodegradable medical devices and materials.
Improves the biocompatibility and safety of the materials, realizes a controllable curing process, and is suitable for the production of medical devices and materials with limited life, ensuring the degradation and tissue repair functions of the materials after a specific time.
Smart Images

Figure CN119081130A_ABST
Abstract
Description
[0001] This application is a divisional application of the invention application with an application date of October 8, 2020, an international application number of PCT / US2020 / 054839, a Chinese national phase application number of 202080071118.7, and an invention name of "Curable Polymer Composition".
[0002] CROSS-REFERENCE TO RELATED APPLICATIONS
[0003] This application claims the benefit of U.S. Provisional Patent Application No. 62 / 913,063, filed on October 9, 2019, under 35 U.S.C. §119(e), which is incorporated herein by reference in its entirety for all purposes. Technical Field
[0004] The present disclosure generally relates to the preparation and use of curable compositions, such as photocurable and thermocurable compositions, to prepare bioresorbable implants by additive manufacturing methods. Background Art
[0005] Stereolithography (SLA) is a relatively well-developed additive printing technology for making three-dimensional (3-D) objects. In the stereolithography process, light, such as ultraviolet (UV) or visible light, is used to photopolymerize liquid materials into designed structures, such as three-dimensional articles, with high accuracy and precision. Successive thin layers are photopolymerized by UV or visible light, for example under the guidance of a sliced CAD (computer-aided design) model.
[0006] SLA typically uses a liquid photopolymerizable polymer composition, which may be referred to as a resin or ink formulation. The macroscopic properties and degradation profile of articles produced by SLA depend in part on the polymer chemistry and processing techniques.
[0007] The present disclosure provides compounds and compositions useful in curing processes such as stereolithography (SLA) that have several advantages over currently known compounds and compositions used for this purpose.
[0008] All subject matter discussed in the background section is not necessarily prior art and should not be considered prior art simply because it is discussed in the background section. Along these lines, any issue in the prior art discussed in the background section or associated with such subject matter should not be considered prior art unless it is explicitly stated to be prior art. Rather, the discussion of any subject matter in the background section should be considered as part of the inventor's way of solving a particular problem, which may itself be inventive. Summary of the invention
[0009] In short, in one aspect, the present disclosure provides compounds and compositions that can be used in a curing process, such as a photocuring process or a thermal curing process such as used in combination with a photocuring process. The curing process can be used to manufacture articles, such as medical devices and coatings. An exemplary curing process is stereolithography (SLA), which is an additive manufacturing method in which a curable composition according to the present disclosure containing one or more photoreactive compounds (including, for example, photoreactive macromers) undergoes photopolymerization (photocuring) during the process of forming a manufactured article. Another exemplary curing process is a coating method in which a compound and / or composition of the present disclosure is placed on a surface and then cured by exposure to heat (thermal curing) and / or cured by exposure to actinic radiation (i.e., photopolymerization or photocuring) to provide a solid coating on the surface. These cured products (i.e., products formed by curing the composition as disclosed herein) may be generally referred to herein as articles, coatings, films, materials, etc. Therefore, when the present disclosure is illustrated by preparing articles, it should be understood that coatings or other materials can be prepared in the same manner. In one aspect, articles, coatings, etc. are biodegradable.
[0010] In one aspect, the present disclosure provides a biodegradable polymer material formed by a curing process. The material can be used to produce an article with a limited lifespan, so that after a period of time, the article formed by the biodegradable material no longer exists. For example, the material can be a coating on a device such as a medical device, wherein the coating degrades after a period of time. In another example, the material can be used to prepare a medical device, such as a mesh for tissue repair, so that after a certain period of time, a portion of the article exists or the article does not exist at all, and tissue repair is completed. As another example, the medical device can be a tissue adhesive or sealant, wherein the polymerizable composition of the present disclosure can be applied to a tissue that needs an adhesive or sealant, and then the composition is exposed to actinic radiation sufficient to cause photopolymerization of the composition on the tissue.
[0011] According to the present disclosure, in one aspect, such materials and articles can be prepared using stereolithography using, for example, compounds and compositions as disclosed herein. The present disclosure addresses issues regarding articles produced by heat- and light-curing materials such as SLA that come into contact with living bodies, including issues regarding the safety and efficacy of the articles produced, particularly their biocompatibility and cytotoxicity.
[0012] In one aspect, the present disclosure provides the preparation and use of polymer compositions. The polymer composition may include a photopolymerizable polymer or be made of a photopolymerizable polymer, including a homopolymer, a copolymer, a block copolymer, a random copolymer, a random block copolymer, or a combination thereof. The polymer composition may include a thermosetting polymer or be made of a thermosetting polymer, including a homopolymer, a copolymer, a block copolymer, a random copolymer, a random block copolymer, or a combination thereof. In one aspect, the polymer composition is a double network, because two chemically different polymers are present in the composition as a blend, wherein optionally the double network polymer composition can be characterized as being solid. In one aspect, the polymer composition is a single network, because a single polymer is present in the composition, wherein optionally the single network polymer composition can be characterized as being solid. In one aspect, the single network includes a cross-linked polymer. In one aspect, the double network includes a cross-linked polymer. The polymer composition can be used, for example, to prepare a bioabsorbable implant by an additive manufacturing method.
[0013] In one aspect, the present disclosure provides a composition comprising (1) a compound having a plurality of photopolymerizable groups, referred to herein as polyhv, and (2) a mixture of two compounds that are thermally reactive (thermally curable) with each other to form a polymer, wherein the two compounds may be referred to herein as polyΔ1 and polyΔ2 or collectively referred to as polyΔ (i.e., polyΔ refers to a mixture of polyΔ1 and polyΔ2). In one aspect, the composition further comprises a photoinitiator. In one aspect, the composition further comprises a stabilizer. In one aspect, the present disclosure provides a cured and optionally crosslinked composition produced by photopolymerization of a composition comprising a photoinitiator, polyhv, and polyΔ, wherein such a cured (e.g., crosslinked) composition may be said to have a single network, which refers to a network formed by polyhv reacting with itself. In one aspect, the present disclosure provides a dual network composition produced by photopolymerization of polyhv and thermal polymerization of polyΔ1 and polyΔ2, wherein each of polyhv and polyΔ forms an independent network, one or both of which are optionally crosslinked networks. The two independent networks together form an interpenetrating dual network. Thus the double network is formed by thermal and photocuring of a composition having thermoreactive components (polyΔ1 and polyΔ2) and at least one photoreactive component (polyhv). In one aspect, photocuring precedes thermal curing. In one aspect, thermal curing precedes photocuring.
[0014] In one aspect, the present disclosure provides a composition comprising 1) a compound having a plurality of photopolymerizable thiol groups, referred to herein as polySH, and 2) a compound having a plurality of photopolymerizable ethylenically unsaturated groups, referred to herein as polyEU, wherein polySH and polyEU are photoreactive with each other. In one aspect, the composition further comprises a photoinitiator. In one aspect, the composition further comprises a stabilizer. In one aspect, the present disclosure provides a single network polymer composition produced by photocuring (photopolymerization) of a composition comprising a photoinitiator, polySH, and polyEU. In one aspect, the present disclosure provides a single network crosslinked composition produced by photocuring (photopolymerization) of a composition comprising a photoinitiator, polySH, and polyEU. In another aspect, the present disclosure provides a single network crosslinked composition produced by photocuring (photopolymerization) of a composition comprising a photoinitiator, a stabilizer, polySH, and polyEU. Exemplary EU groups are acrylate, methacrylate, and norbornene, wherein polyEU refers to a compound comprising a plurality of EU groups (optionally two EU groups or three EU groups or four EU groups).
[0015] In one aspect, disclosed herein are methods and compositions for curing processes such as 3-D printing and for preparing and using the resulting cured articles. For example, the present disclosure provides a method for photopolymerized printed articles, the method comprising: a) exposing a photopolymerizable composition to light of a suitable wavelength for a period of time, the photopolymerizable composition comprising polyEU macromers and polySH as disclosed herein; optionally combined with one or more other components such as at least one photoinitiator component and / or at least one light reflective material component (comprising a light reflective material) suspended in the composition and / or at least one stabilizer; and forming a printed article comprising a polymerized product of the photopolymerizable composition. In another aspect, the present disclosure provides a method for photopolymerized printed articles, comprising: a) exposing a photopolymerizable composition comprising polyhv, polyΔ1, and polyΔ2 to light of a suitable wavelength for a period of time; and b) thermally polymerizing polyΔ1 and polyΔ2; optionally combined with one or more other components such as at least one photoinitiator component and / or at least one light reflective material component (comprising a light reflective material) suspended in the composition and / or at least one stabilizer; and forming a printed article comprising a polymerized product of the photopolymerizable composition.
[0016] In one aspect, disclosed herein are methods and compositions for photopolymerization processes such as film-forming processes including coating processes, and for preparing and using such photopolymerizable materials. For example, the present disclosure provides a method for photopolymerizable coating of an article, the method comprising: a) applying a photopolymerizable composition of the present disclosure to a surface, b) exposing the photopolymerizable composition to light of a suitable wavelength for a period of time, the photopolymerizable composition comprising polyEU macromers and polySH as disclosed herein; optionally in combination with one or more other components such as at least one photoinitiator component and / or at least one light reflective material component (comprising a light reflective material) suspended in the composition and / or at least one stabilizer; and forming a solid coating comprising a polymerization product of the photopolymerizable composition.
[0017] In other aspects, the present disclosure provides a polymerized product of a macromer (which may also be referred to as a prepolymer), wherein the macromer has been polymerized by, for example, one or more methods disclosed herein. In addition, the present disclosure provides an article (which may be referred to as a polymer article) produced by a photopolymerizable compound or composition disclosed herein, optionally produced by one or more methods disclosed herein. The photopolymerized macromer or article may be a non-toxic article. In addition, the article may contain a biodegradable photopolymerizable macromer, optionally in a blend with a non-toxic amount of a photoinitiator. Optionally, the article may contain a biodegradable photopolymerizable macromer, optionally in a blend with a non-toxic amount of a stabilizer. Optionally, the article may contain a biodegradable photopolymerizable macromer, optionally in a blend with a non-toxic amount of a UV reflective material. In one aspect, the polymer article is biodegradable in whole or in part under physiological conditions. However, in an alternative aspect, the polymer article is not biodegradable under physiological conditions.
[0018] In addition, the present disclosure provides a photopolymerizable compound (also referred to herein as a macromonomer) comprising a multiaxial central core (CC) and 2-4 arms of formula (A)-(B) or (B)-(A) extending from the central core, wherein at least one of the arms comprises a photoreactive functional group (Q), and (A) is a polymerization product of monomers selected from propylene carbonate (also referred to herein as T or TMC) and ε-caprolactone (also referred to herein as caprolactone or C or CAP), and (B) is a polymerization product of monomers selected from glycolide, lactide, and p-dioxanone. The macromonomer can be the photopolymerizable macromonomer component of the compositions and methods disclosed herein, and can be photopolymerized to provide an article.
[0019] Optionally, any of the compositions of the present disclosure may contain an effective amount of a photoinitiator before they are cured, i.e., an amount of photoinitiator effective to effect polymerization of the photopolymerizable compound when the composition is exposed to radiation emitted from a light source that delivers light of a selected wavelength suitable to activate the photoinitiator.
[0020] In one aspect, the present disclosure provides a method of 3D printing (also known as additive printing, such as stereolithography), the method comprising: providing a polymerizable composition disclosed herein having a photopolymerizable compound and a photoinitiator, and exposing the composition to light effective to activate the photoinitiator to photopolymerize the photopolymerizable compound in the polymerizable composition. In one aspect, the composition is selectively exposed to light so that a selected portion of the composition, but not all, undergoes photopolymerization. In one aspect, the photopolymerizable compound is a mixture including one or more polyhv compounds (e.g., two photopolymerizable compounds represented herein as polyEU and polySH). In one aspect, one or more photopolymerizable compounds are mixed with one or more thermoreactive compounds (e.g., two thermoreactive compounds represented herein as polyΔ1 and polyΔ2).
[0021] The above and additional features of the present disclosure and the manner in which they are obtained will become apparent, and the present disclosure will be best understood by reference to the following more detailed description.All references disclosed herein are incorporated herein by reference in their entirety, just as if each reference was incorporated individually.
[0022] This brief summary is provided to introduce some concepts in a simplified form that are further described in the detailed description below. Unless otherwise expressly stated, this brief summary is not intended to identify key or essential features of the claimed subject matter, nor is it intended to limit the scope of the claimed subject matter.
[0023] The details of one or more embodiments are set forth in the following description. Features shown or described in conjunction with an exemplary embodiment may be combined with features of other embodiments. Therefore, any of the various embodiments described herein may be combined to provide further embodiments. If it is necessary to adopt the concepts of various patents, applications, and publications as identified herein, aspects of the embodiments may be changed to provide other embodiments. Other features, objects, and advantages will be apparent from the specification, drawings, and claims.
[0024] The above and additional features of the present disclosure and the manner in which they are obtained will become apparent, and the present disclosure will be best understood by reference to the following more detailed description.All references disclosed herein are incorporated herein by reference in their entirety, just as if each reference was incorporated individually. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] The exemplary features of the present disclosure, its nature and various advantages will become apparent from the following detailed description of the accompanying drawings and various embodiments. Non-limiting and non-exhaustive embodiments are described with reference to the accompanying drawings, wherein similar marks or reference numerals refer to similar parts in each of the different views unless otherwise indicated. The sizes and relative positions of the elements in the accompanying drawings are not necessarily drawn to scale. For example, the shapes of various elements are selected, enlarged and positioned to improve the readability of the drawings. For ease of identification in the accompanying drawings, specific shapes of the drawn elements have been selected. One or more embodiments are described below with reference to the accompanying drawings, in which:
[0026] Figure 1 Degradation graphs for selected cured compositions of the present disclosure are shown.
[0027] Figure 2 Shown are water swelling graphs for selected cured compositions of the present disclosure. DETAILED DESCRIPTION
[0028] By referring to the preferred embodiments of the present disclosure below and the detailed description of the examples included therein, the present disclosure can be more easily understood.When reading this detailed description, unless otherwise stated, all technical and scientific terms used herein have the same meanings as those of ordinary skill in the art to which the present disclosure belongs, as generally understood.Unless the context clearly states otherwise, the singular terms "a", "an" and "the" include plural references.Similarly, unless the context clearly states otherwise, the term "or" is intended to include "and".The term "including" means "comprising".The abbreviation "for example (eg)" is derived from Latin exempli gratia, and is used herein to represent non-limiting examples.Therefore, the abbreviation "for example (eg)" is synonymous with the term "for example (for example)".
[0029] In one aspect, the present disclosure provides a composition that is liquid at a temperature of about room temperature (i.e., about 18°C to about 23°C), and that can be cured. The curing process will include photocuring (also referred to herein as photopolymerization), and depending on the composition, may also include thermal curing (also referred to herein as thermal polymerization). Photocuring occurs when the composition is exposed to actinic radiation of the required energy for a selected period of time, thereby causing a reaction between the photochemical (also referred to herein as photoreactive or photopolymerization, etc.) components of the composition and an increase in the average molecular weight of the components in the composition. Thermal curing is a corresponding process achieved when the composition is heated to a suitable temperature for a suitable length of time at a temperature above room temperature, thereby causing a reaction between the thermoreactive (also referred to herein as thermoreactive or thermopolymerization, etc.) components of the composition and an increase in the average molecular weight of the components in the composition. When the reactants include compounds having three or more photoreactive or thermoreactive chemical groups, the curing process will be provided to a composition having a crosslinking component. As used herein, curing refers to photocuring, optionally with thermal curing if the composition has a thermoreactive component.
[0030] The composition of the present disclosure includes a photoreactive component. Optionally, the composition may also include a thermally reactive component. When the composition includes both thermally and photochemically reactive components, the resulting cured composition may be referred to herein as having a dual network or double network: a first network formed by the photochemically reactive compound and a second network formed by the thermally reactive compound. When the composition has a photochemically reactive component but does not have a thermally reactive component, the resulting cured composition may be referred to herein as having a single network.
[0031] As explained in further detail below, the compositions of the present disclosure may include one or more compounds having at least two photochemically reactive functional groups (denoted as "hv" groups), and may optionally include two or more compounds having at least two thermally reactive functional groups (denoted as "Δ" groups). The reactive functional groups will be attached to an organic backbone, i.e., a backbone consisting of atoms including carbon and hydrogen. As a simple example, if the Δ group is a hydroxyl group, the thermally reactive compound may be ethylene glycol, i.e., HO-CH2-CH2-OH, where the backbone is -CH2-CH2-.
[0032] When the main chain of a compound includes repeated chemical units, the compound may be referred to herein as a macromonomer. For example, a reaction between a small amount of ethylene glycol (referred to as an initiator) and a large amount of a hydroxy acid or equivalent (e.g., lactic acid or lactide) will produce a compound having two polylactides (repeating lactide units) extending from either end of the ethylene glycol initiator and also having a hydroxyl group at each of the two ends of the polylactide chain. In one aspect, the composition of the present disclosure includes a macromonomer as a photochemically reactive component, and / or a macromonomer as a thermally reactive component.
[0033] Compounds with two or more hydroxyl groups are exemplary heat-reactive compounds of the present disclosure. Such hydroxyl-containing compounds are heat-reactive with compounds having complementary functional groups such as epoxide or isocyanate groups. Therefore, the composition of the present disclosure can have a first compound with two or more hydroxyl groups and a second compound with two or more functional groups that are heat-reactive with hydroxyl groups. In one aspect, hydroxyl groups are an example of nucleophilic groups, and epoxides are an example of electrophilic groups. Therefore, in one aspect, the heat-reactive composition of the present disclosure can be described as having a compound with two or more nucleophilic groups and a compound with two or more electrophilic groups.
[0034] In addition to being a compound that can be used for the heat-curable composition disclosed herein, hydroxyl-containing compounds are also useful starting materials for preparing photoreactive compounds. For example, as disclosed herein, hydroxyl groups can be converted into thiol-containing groups. In addition, hydroxyl groups can be converted into groups with ethylenically unsaturated moieties. Therefore, the main chain of the hydroxyl-containing compound as disclosed herein can also exist as the main chain or part of the main chain of the photochemically reactive compound in the composition disclosed herein. It should be understood that when the present disclosure provides a compound with two or more hydroxyl groups, the present disclosure also provides that the main chain of the hydroxyl-containing compound is optionally present in the photochemically reactive compound of the present disclosure.
[0035] PolyΔ Compounds
[0036] In one aspect, the present disclosure provides a composition comprising two polyΔ compounds represented herein as polyΔ1 and polyΔ2. The compound polyΔ1 has multiple (hence "poly") Δ1 groups, wherein the Δ1 groups are thermally reactive with the Δ2 groups. The compound polyΔ2 has multiple Δ2 groups, wherein the Δ2 groups are thermally reactive with the Δ1 groups. Each of polyΔ1 and polyΔ2 is an organic compound. The term "thermally reactive" means that heat must be applied to the composition comprising polyΔ1 and polyΔ2 in order for Δ1 and Δ2 to react with each other. At room temperature (i.e., about 22° C.), and in the absence of a catalyst, Δ1 and Δ2 do not react with each other to any significant extent. In one embodiment, the composition of the present disclosure does not include a catalyst for increasing the rate of the thermal reaction. After the reaction, Δ1 and Δ2 form one or more covalent bonds so that polyΔ1 and polyΔ2 become part of a polymer network, optionally part of a cross-linked polymer network.
[0037] In one aspect, the polyol (also referred to as a polyol) is a polyΔ compound. For example, an aliphatic polyol having an alkylene group can be used as a polyΔ. Exemplary alkylene groups include ethylene, propylene (branched or linear), butylene (branched or linear), hexylene (branched, linear or cyclic), and octylene (branched, linear or cyclic). Exemplary polyols having more than two hydroxyl groups (which can be used when crosslinking is desired) include trimethylolpropane, glycerol, pentaerythritol, 1,2,4-butanetriol, and 2,3,4-pentanetriol.
[0038] In one aspect, aromatic diols can be used as polyΔ. Examples include catechol, resorcinol, hydroquinone, and reaction products thereof, such as the reaction product of the multiple reaction products of resorcinol and ethylene carbonate. Other suitable aromatic diols include bisphenol A and 4,4'-dihydroxybiphenyl.
[0039] In one aspect, polyether glycols can be used as polyΔ compounds. Polyether glycols introduce polyoxyalkylene segments (in other words, polyether segments) into the curing composition. Polyether glycols can include homopolymers of oxyalkylene groups, or copolymers of two different oxyalkylene groups. The copolymers can be random or block copolymers, such as diblock copolymers or triblock copolymers. Exemplary oxyalkylene moieties include ethylene oxide, 1,2 propylene oxide, 1,3 propylene oxide (oxytrimethylene) and 1,4 butylene oxide (oxytetramethylene).
[0040] In one aspect, polycarbonate diols can be used as polyΔ. Examples include trimethylene carbonate, poly(hexamethylene carbonate) glycol, poly(ethylene carbonate) glycol, poly(propylene carbonate) glycol, and poly(butylene carbonate) glycol.
[0041] Exemplary polyΔ macromonomers can have a multiaxial central core (CC) and 2-4 arms with repeating units. Such polyΔ macromonomers may be referred to herein as multiaxial macromonomers. In one embodiment, at least two of the arms terminate in a nucleophilic group, such as a hydroxyl or amine group. In one aspect, the repeating units are all identical, i.e., the arms are homopolymers. In one aspect, the repeating units are not identical, i.e., the arms are copolymers. The copolymers may be random or block copolymers. For example, and as further discussed below, the arms may have the formula (A)-(B) or (B)-(A) extending from the central core. The arms may be biodegradable or non-biodegradable.
[0042] In one aspect, the arm includes an ester group, and the arm can be said to be a polyester. In order to form an ester group, the arm can be prepared in whole or in part by a hydroxy acid or an equivalent. Exemplary hydroxy acids and equivalents include glycolic acid (and its equivalent, glycolide), lactic acid (and its equivalent, lactide), ε-caprolactone (C) and p-dioxanone. In one aspect, the arm is all formed by the same monomer so that the multiaxial macromolecular monomer has a homopolymer arm. In one aspect, the arm can include a carbonate group. In order to form a carbonate group, the arm can be prepared in whole or in part by trimethylene carbonate (also represented as "T" in this article).
[0043] In one aspect, the polyΔ compound can be a multiaxial macromonomer having a central core and a plurality of, for example, 2-4, copolymer arms extending from the central core, each arm terminating (i.e., terminating) in a thermally reactive group such as a hydroxyl group. The compound can be of the formula CC-[armΔ] n , wherein CC represents a central core and n is selected from a number in the range of 2-18, or 2-14, or 2-8, or 2-6, or 2-4. Each arm is formed by polymerization of monomers selected from two groups, which are denoted as Group A and Group B. Therefore, more specifically, in the compounds of the present disclosure, CC-[armΔ] nIt can be written as CC-[(A)p-(B)q-OH]n or CC-[(B)q-(A)p-OH]n, where each of (A)p-(B)q and (B)q-(A)p represents an arm. Optionally, the terminal functional group of the arm can be shown, where an exemplary terminal functional group is hydroxyl. In this formula, A represents the polymerization product of one or more monomers, the monomers include and optionally are selected only from propylene carbonate (T or TMC) and caprolactone (C or CAP), and p represents the number of monomers that have been polymerized to form the polymerization product A, where p is selected from 1-40, or 1-30, or 1-20, or 1-10. In the formula, B represents a polymerization product of one or more monomers including and optionally selected only from glycolide (G or GLY), lactide (L or LAC) and p-dioxanone (D or DOX), and q represents the number of monomers that have been polymerized to form the polymerization product B, wherein q is selected from 1-40, or 1-30, or 1-20, or 1-10.
[0044] For example, when the formula CC-[arm] n When the compound is formed by a trifunctional central core and A is added to CC before B, the formula is CC-[armΔ] n The compound can be written as CC-[(A)p-(B)q-OH]3. In this example, if A is formed by the polymerization of two Ts and one C, then p will be three in each arm and A will be independently selected from TTT, TTC, TCT, TCC, CCC, CCT, CTC, and CTT. Continuing with this example, if B is formed by the polymerization of one G, then q will be one and B will be G. In this example, each arm will have a chemical formula selected from TTTG, TTCG, TCTG, TCCG, CCCG, CCTG, CTCG, and CTTG. This exemplary compound can be written as CC-[armΔ]3, wherein each arm is independently selected from TTTG-OH, TTCG-OH, TCTG-OH, TCCG-OH, CCCG-OH, CCTG-OH, CTCG-OH and CTTG-OH, or alternatively as CC-[(T,T,C)-(G)-OH]3 or CC-[(T,T,C)3-(G)1-OH]3.
[0045] In one aspect, the present disclosure provides a composition comprising a compound having a difunctional central core and 2 arms extending from the central core, each arm terminating in a hydroxyl group. In one embodiment, the present disclosure provides a composition comprising a compound, and the compound comprises a trifunctional central core and 2 or 3 arms extending from the central core, each arm terminating in a hydroxyl group. In one embodiment, the present disclosure provides a composition comprising a compound, and the compound comprises a tetrafunctional central core and 2 or 3 or 4 arms extending from the central core, each arm terminating in a hydroxyl group. Each arm in the compound can be a homopolymer or a copolymer, and when it is a copolymer, it can be a random copolymer or a block copolymer, such as a block copolymer represented by formula (A)-(B) or (B)-(A). When the compound is prepared by reacting the central core with a monomer of A, and then reacting the reaction product with one or more monomers selected from Group B, the compound will have the formula CC-[(A)-(B)-OH]. However, when the composition is prepared by reacting the central core with monomers from Group B and then reacting the reaction product with one or more monomers from Group A, then the compound will have the formula CC-[(B)-(A)-OH].
[0046] In embodiments, the macromonomer will have a molecular weight of less than 250,000 Da, or less than 200,000 Da, or less than 150,000 Da, or less than 100,000 Da, or less than 50,000 Da, or less than 25,000 Da, or less than 20,000 Da, or less than 15,000 Da, or less than 10,000 Da, or less than 9,000 Da, or less than 8,000 Da, or less than 7,000 Da, or less than 6,000 Da, or less than 5,000 Da, or less than 1,000 Da.
[0047] In an embodiment, the multiaxial macromonomers present in the composition all contain the same central core. For example, all macromonomer components of the composition are prepared from trimethylolpropane or pentaerythritol. However, in one aspect, the composition of the present disclosure contains a mixture of multiaxial macromonomer components, for example, some of the macromonomer components are triaxial, prepared from, for example, trimethylolpropane, and other macromonomer components of the same composition are quadriaxial, prepared from, for example, pentaerythritol.
[0048] In an embodiment, the multiaxial macromolecular monomer of the present disclosure has relatively short arms, for example, 1-10 monomer residues / arm. As used herein, a monomer residue refers to the polymerization product of a monomer, that is, the structure that the monomer has after the monomer has been incorporated into a polymer and thus provides a monomer residue in the polymer. In one embodiment, when the compounds of the present disclosure are used for additive manufacturing, those compounds should be in a liquid state: either the compound itself is a fluid or the compound is dissolved in a solvent and / or a diluent to provide a fluid composition. If the arm is too long, the composition containing the compound will typically be too viscous to be used for additive printing such as SLA, unless the composition contains a large amount of solvent or diluent to dilute the compound, in which case the additive printing process may need to utilize an undesirable large amount of solvent. Advantageously, when the arm is relatively short, the compound itself can be a fluid at the application temperature of the additive printing process. In one aspect, the application temperature is room temperature, i.e., about 18°C to about 23°C, and the composition is a liquid at this temperature.
[0049] In optional embodiments, the compounds of the present disclosure and compositions containing such compounds can be described by one or more of the following features characterizing the A region (also referred to as a block) of the multiaxial macromonomer: having a block A comprising residues formed from propylene carbonate (TMC or T), i.e., the residues are polymers or residues of TMC; having a block A comprising residues formed from caprolactone (CAP or C); having a block A comprising residues formed from both TMC and CAP; having at least 90% of the residues in block A being residues formed from TMC or CA; having at least 90% of the residues in block A being residues formed from TMC or CA; having at least 90% of the residues in block A being residues formed from TMC or CA. The compound contains 1-45 or 2-45 residues formed by TMC; the compound contains 1-15 or 2-15 residues formed by TMC; the compound contains 1-10 or 2-10 residues formed by TMC; the molecular weight of region A is 102-2500g / mol; the molecular weight of region A is 102-1000g / mol; the molecular weight of region A is 102-900g / mol; each A region contains 2-45 monomer residues; each A region contains 2-15 monomer residues; each A region contains 2-10 monomer residues.
[0050] In optional embodiments, compounds of the present disclosure and compositions containing such compounds can be described by one or more of the following features characterizing the B blocks (also referred to as regions) of the multiaxial macromolecular monomer: each B block contains 1-45 or 2-45 monomer residues; each B block contains 1-15 or 2-15 monomer residues; each B block contains 1-10 or 2-10 monomer residues.
[0051] In one aspect, the polyamine is a polyΔ compound. For example, aliphatic polyamines having an alkylene group can be used as polyΔ. Exemplary alkylene groups include ethylene, propylene (branched or linear), butylene (branched or linear), hexylene (branched, linear or cyclic), and octylene (branched, linear or cyclic). Exemplary polyamines having more than two amine groups include polypropylene imine tetramine (also known as Dab-Am-4) and triethylenetetramine. Huntsman Company sells many suitable polyamines having more than two amine groups, such as polyether triamine (Huntsman product XTJ-566), JEFF ST-404 polyetheramine (Huntsman products (XTJ-586) and JEFF T-403 polyetheramine.
[0052] In one aspect, aromatic diamines can be used as polyΔ. Examples include 1,2-diaminobenzene, 1,3-diaminobenzene, 1,4-diaminobenzene, toluenediamine (e.g., 1,2-diamino-3-methylbenzene, 1,2-diamino-4-methylbenzene, 1,3-diamino-2-methylbenzene, 1,3-diamino-4-methylbenzene, 1,4-diamino-2-methylbenzene, 1,4-diamino-3-methylbenzene), alkyl-substituted toluenediamines (e.g., 3,5-diethyltoluene-2,4-diamine and 3,5-diethyltoluene-2,6-diamine), and p-xylylenediamine.
[0053] In one aspect, polyether diamines can be used as polyΔ compounds. When a polyether diamine is reacted with a polyΔ containing a diisocyanate, the result will be a polyether urea moiety. The polyether diamine can include a homopolymer of an oxyalkylene group or a copolymer of two different oxyalkylene groups. The copolymer can be a random or block copolymer, for example, a diblock copolymer or a triblock copolymer. Exemplary oxyalkylene moieties include ethylene oxide, 1,2 propylene oxide, 1,3 propylene oxide, and 1,4 butylene oxide.
[0054] In one aspect, the polyisocyanate is a polyΔ compound. An exemplary polyisocyanate compound is an aliphatic polyisocyanate, such as, but not limited to, tetramethylene diisocyanate, 1-lysine diisocyanate, ethyl lysine diisocyanate, hexamethylene diisocyanate, octamethylene diisocyanate, decamethylene diisocyanate, dodecamethylene diisocyanate, and cyclohexane bis-(methylene isocyanate). Another exemplary polyisocyanate compound is an aromatic polyisocyanate, such as, but not limited to, 4,4,-diphenylmethane diisocyanate (MDI), 2,4-toluene diisocyanate (TDI), 1,5-naphthalene diisocyanate, and isophorone diisocyanate.
[0055] In one aspect, polyisocyanate polyΔ is a macromonomer having multiple isocyanate groups. Such macromonomers may be referred to herein as polyisocyanate macromonomers. Polyisocyanate macromonomers may be prepared from corresponding polyhydroxylated macromonomers by reacting polyhydroxylated monomers with diisocyanates such as hexamethylene diisocyanate.
[0056] Exemplary polyisocyanate macromers are the reaction products of reactants comprising or consisting of diisocyanates and one or both of diamines and diols (e.g., polyether diamines or polyether diols). Such polyisocyanate macromers have terminal isocyanate groups that are reactive with additional polyamines and / or polyols. For example, a diisocyanate can be used to form a macromer by reaction with a diamine or diol to provide a polyΔ compound (e.g., a polyΔ2 compound) having a terminal isocyanate group. This polyΔ2 polyisocyanate macromer can then be thermally reacted with additional diamines or diols (polyΔ1 compounds) to form a thermally cured polymer in the composition of the present disclosure.
[0057] In one aspect, the present disclosure provides a polyisocyanate macromonomer, which is a reaction product of a polyisocyanate, such as a diisocyanate, and a polyol, such as a diol, such as a polyether diol. Optionally, any one or more of the following may be used to further describe the polyisocyanate macromonomer and its preparation: the polyol is a diol and the polyisocyanate is a diisocyanate, the diol may be a polyether diol containing at least one type of oxyalkylene sequence selected from the group consisting of ethylene oxide, 1,2-propylene oxide, 1,3-propylene oxide, and 1,4-butylene oxide; the polyol may be an aliphatic polyol with an alkylene group, wherein exemplary alkylene groups include ethylene, propylene (branched or linear), butylene (branched or linear), hexylene (branched, linear or cyclic), and octylene (branched, linear or cyclic). Exemplary polyols having more than two hydroxyl groups (which may be used when crosslinking is desired) include trimethylolpropane, glycerol, pentaerythritol, 1,2,4-butanetriol and 2,3,4-pentanetriol. The polyol may be an aromatic diol, examples of which include catechol, resorcinol, hydroquinone and reaction products thereof, such as the reaction product of resorcinol and ethylene carbonate. Other suitable aromatic diols include bisphenol A and 4,4′-dihydroxybiphenyl.
[0058] In one aspect, a polyisocyanate macromer (which is the reaction product of a polyisocyanate, such as a diisocyanate, and a polyol, such as a diol, such as a polyether diol) provides a polyΔ2 compound (which can react with a polyΔ1 compound, such as a polyamine). The reaction product can be described in terms of its structural components rather than the reactants from which it can be formed. In one aspect, the polymer chain is a polyurea, having a plurality of urea groups alternately separated by aliphatic groups (provided by the aliphatic diamine) and polymer blocks (provided by the macromer). In other words, the structure can be described by repeating -[urea-aliphatic-urea-polymer block]-units. The polymer blocks are polyurethanes, which have a plurality of urethane (also called carbamate) groups alternately separated by aliphatic groups (provided by the diisocyanate) and polyether groups. In other words, the structure of the polymer blocks can be described by repeating -[urethane-aliphatic-urethane-polyether]-units. The polyether segments may optionally be selected from ethylene oxide, ethylene oxide, 1,2 propylene oxide, 1,3 propylene oxide and 1,4 butylene oxide, and in one embodiment, the polymer chain contains more than one of these polyether segments, for example, the polymer contains ethylene oxide, propylene oxide and 1,4 butylene oxide groups, wherein optionally the ethylene oxide and propylene oxide are arranged in a block copolymer arrangement (e.g., ethylene oxide block-propylene oxide block-ethylene oxide block). The polymer blocks may also be referred to as polyether polyurethanes, and the polymers themselves may be referred to as polyether urethane ureas.
[0059] When the composition includes a polyisocyanate as a polyΔ compound, for example, as a polyΔ2, the composition will also include a compound that is reactive with the polyisocyanate, i.e., a polyΔ1 compound such as a polyol, wherein the reaction of the polyisocyanate and the polyol produces a urethane group. Another example of an isocyanate-reactive group is an amine group, so that when the composition contains a polyisocyanate as a polyΔ2, the composition may also include a polyamine compound as a polyΔ1, wherein the reaction of the polyisocyanate and the polyamine produces a urea group.
[0060] In one aspect, the polyΔ compound is a polyepoxide. Exemplary polyepoxides include, but are not limited to, diepoxides, triepoxides, and tetraepoxides. In one aspect, polyΔ2 is a diepoxide. Exemplary polyepoxides include diepoxide (also known as butane diepoxide, butadiene diepoxide, or 1,2:3,4-diepoxybutane); 1,2,7,8-diepoxyoctane; 1,4-butanediol diglycidyl ether; polyglycerol polyglycidyl ether; ethylene glycol diglycidyl ether; polyethylene glycol diglycidyl ether having a molecular weight of about 500 to about 6,000; polypropylene glycol diglycidyl ether having a molecular weight of about 500 to about 6,000.
[0061] The present disclosure provides polyΔ compounds, wherein Δ is a hydroxyl group. Such compounds can be converted to polyΔ compounds, wherein Δ is an epoxy group, thereby providing polyepoxide compounds of the present disclosure. For example, a polyhydroxy compound can be reacted with an excess equivalent of epichlorohydrin and then treated with a base such as sodium hydroxide to convert the hydroxyl group to an epoxy group.
[0062] In one aspect, Δ1 is a nucleophilic group. In one embodiment, polyΔ1 has multiple hydroxyl (-OH) groups. In one embodiment, polyΔ1 has multiple amine groups (-NH2). In one embodiment, polyΔ1 does not react with itself. In one embodiment, the only reactive groups present on polyΔ1 are Δ1 groups, and all Δ1 groups are the same, for example, they are all hydroxyl groups. In one embodiment, polyΔ1 has two Δ1 groups. In one embodiment, polyΔ1 has three Δ1 groups. In one embodiment, polyΔ1 has four Δ1 groups. In one embodiment, polyΔ1 has more than four Δ1 groups. All other factors being equal, the more Δ1 groups present as part of polyΔ1, the more crosslinking will occur by the composition comprising polyΔ1.
[0063] In one aspect, Δ2 is an electrophilic group. In one embodiment, polyΔ2 has a plurality of epoxide (-CH(O)CH-) groups. In one embodiment, polyΔ2 has a plurality of isocyanate (-N=C=O) groups. In one embodiment, polyΔ2 does not react with itself. In one embodiment, the only reactive groups present on polyΔ2 are Δ2 groups, and all Δ2 groups are the same, e.g., they are all isocyanate groups. In one embodiment, polyΔ2 has two Δ2 groups. In one embodiment, polyΔ2 has three Δ2 groups. In one embodiment, polyΔ2 has four Δ2 groups. In one embodiment, polyΔ2 has more than four Δ2 groups. All other factors being equal, the more Δ2 groups present as part of polyΔ2, the more crosslinking will occur from a composition comprising polyΔ2.
[0064] In one aspect, polyΔ1 is a polyol and polyΔ2 is a polyepoxide.
[0065] In one aspect, polyΔ1 is a polyol and polyΔ2 is a polyisocyanate.
[0066] In one aspect, polyΔ1 is a polyamine compound and polyΔ2 is a polyepoxide.
[0067] In one aspect, polyΔ1 is a polyamine compound and polyΔ2 is a polyisocyanate.
[0068] In one aspect, polyΔ1 is a polythiol compound and polyΔ2 is a polyepoxide.
[0069] In one aspect, polyΔ1 is a polythiol compound and polyΔ2 is a polyisocyanate.
[0070] In one aspect, the compositions of the present disclosure include a photoinitiator.
[0071] Polyhv Compounds
[0072] The Polyhv compound of the present disclosure contains multiple photopolymerizable groups hv. An exemplary photopolymerizable group is an ethylenically unsaturated group, and an exemplary polyhv compound having an ethylenically unsaturated group can be represented as polyEU. Another exemplary photopolymerizable group is a thiol group, and an exemplary polyhv compound having a thiol group can be represented as polySH.
[0073] In one aspect, the disclosure provides a multi-arm compound as described herein, wherein the arm terminates in an hv group and the hv group is photopolymerizable. In one embodiment, an exemplary hv group may contain a photopolymerizable thiol group. In one embodiment, an exemplary hv group may contain a photopolymerizable carbon-carbon double bond, for example, the arm may contain a vinyl group, such as the vinyl group present in an acrylate or methacrylate group, each having a photopolymerizable carbon-carbon double bond.
[0074] Hv groups containing photopolymerizable components such as photopolymerizable thiols or carbon-carbon double bonds can be introduced into multi-arm compounds as described herein by reaction of terminal hydroxyl groups with suitable reagents. Methods for converting hydroxyl groups into thiol-containing groups or carbon-carbon double bond-containing groups are generally known and can be used to prepare compounds of the present disclosure, examples of which are provided herein.
[0075] Although the hv group will contain a photoreactive group, and in particular, will contain a photoreactive group that allows polymerization of a macromer containing hv, the hv group may also contain additional atoms that affect the photoreactivity of the photoreactive group (e.g., a carbonyl group adjacent to a carbon-carbon double bond as exemplified herein) and / or be used to introduce a photoreactive group into a macromer as exemplified herein, for example, a succinate ester may be used to introduce a thiol group.
[0076] For example, in order to convert a hydroxyl group into an hv group containing a photopolymerizable carbon-carbon double bond (polyEU), a multi-arm compound having terminal hydroxyl groups as described herein can be reacted with a reactive acrylate, methacrylate or norbornene-based compound such as methacrylic anhydride, acrylic anhydride, methyl-5-norbornene-2,3-dicarboxylic anhydride, 5-norbornene-2,3-dicarboxylic anhydride, methacryloyl chloride or acryloyl chloride.
[0077] For example, in order to convert a hydroxyl group into an hv group containing a photopolymerizable thiol group (polySH), a multi-arm compound having a terminal hydroxyl group as disclosed herein can be subjected to an esterification reaction. A method for esterification is to add a stoichiometric amount of a macromonomer and a mercaptocarboxylic acid compound in the presence of a carbodiimide (e.g., N, N′-dicyclohexylcarbodiimide) and a catalyst (e.g., dimethylaminopyridine). Exemplary mercaptocarboxylic acids include, but are not limited to, the following compounds: 3-mercaptopropionic acid, thiolactic acid, thioglycolic acid, mercaptobutyric acid, mercaptohexanoic acid, mercaptobenzoic acid, mercaptoundecanoic acid, mercaptooctanoic acid, and n-acetylcysteine. For example, a multi-arm compound having a terminal hydroxyl group as disclosed herein can be reacted with thiolactic acid, in which case the resulting Q group has the formula -C(=O)-CH2-SH attached to the terminal oxygen of the multi-arm compound.
[0078] Another exemplary method of forming a thiol functionalized macromonomer (polySH) is to first make the corresponding hydroxyl-terminated macromonomer to form a terminal carboxylic acid group. Such an example is to react the hydroxyl-terminated macromonomer with succinic anhydride. Using the terminal carboxylic acid group, the macromonomer can be reacted with a mercapto alcohol or with a mercaptoamine by esterification to form an amide bond. Some examples of mercapto alcohols include, but are not limited to, the following: mercaptopropanol, mercaptohexanol, mercaptooctanol, and mercaptoundecanol. Some examples of mercaptoamines include, but are not limited to, the following: cysteine, glutathione, 6-amino-1-hexanethiol hydrochloride, 8-amino-1-octanethiol hydrochloride, and 16-amino-1-hexadecanethiol hydrochloride. For example, a multi-arm compound having a terminal hydroxyl group as disclosed herein can be reacted with succinic anhydride to form an intermediate, which is then reacted with cysteine to introduce a terminal thiol group, in which case the polySH compound includes a moiety of the formula -C(=O)CH2CH2C(=O)NH-C(COOH)-CH2SH having a terminal oxygen attached to the multi-arm compound.
[0079] Yet another method for forming thiol functionalized macromonomer polySH is to react a macromonomer with terminal hydroxyl groups with a lactone monomer with pendant thiol groups. This will be done in the third step of ring-opening polymerization.
[0080] In one aspect, polySH compounds are macromonomers called thiol polymers (thiomers). In some aspects, thiol compounds are multi-arm poly (ethylene glycol) (PEG) comprising at least two free thiol groups or multi-arm poly (ethylene oxide) comprising at least two free thiol groups. Exemplary thiol polymers include but are not limited to 4-arm-PEG2K-SH, 4-arm-PEGSK-SH, 4-arm-PEG10K-SH, 4-arm-PEG20K-SH, 4-arm-PEG10K-SH, 4-arm-PEG20K-SH, thiol-terminated 4-arm poly (ethylene oxide), 8-arm-PEG10K-SH (six glycerol core), 8-arm-PEG10K-SH (tripentaerythritol core), 8-arm-PEG20K-SH (six glycerol core), 8-arm-PEG20K-SH (tripentaerythritol core) and thiol-terminated 8-arm poly (ethylene oxide). These thiol polymers are available from Millipore Sigma (formerly SigmaAldrich).
[0081] In one aspect, polySH is not a macromonomer, but a small molecule with a molecular weight of less than 1000 Daltons. Optionally, the small molecule polySH may be water soluble. Examples of such polySH compounds include dithiol compounds, trithiol compounds, and tetrathiol compounds. Exemplary polySH compounds include, but are not limited to, dithiothreitol (DTT); 1,2-ethanedithiol; 1,3-propanedithiol; 1,4-butanedithiol; 1,5-pentanedithiol; 1,6-hexanedithiol; 1,7-heptanedithiol; 1,8-octanedithiol; 1,9-nonanedithiol; 1,10-decanedithiol; 1,11-undecanedithiol; 1,12-dodecanedithiol; 1,13-tridecanedithiol; 1,14-tetradecanedithiol; 1,16-hexadecanedithiol; dithiobutylamine (DTBA); tetra(ethylene glycol)dithiol; hexa(ethylene glycol)dithiol; 2-mercaptoethyl ether; 2,2′-thiodiethanethiol; 2,2′-(ethylenedioxy)diethanethiol; propane-1,2,3-trithiol; trihydroxy Methylpropane tris(2-mercaptoacetate); trimethylolpropane tris(3-mercaptoacetate); pentaerythritol tetrathiol; pentaerythritol tetra(3-mercaptopropionate); 1,2-dithiane-4,5-diol; lipoic acid (alpha lipoic acid and beta lipoic acid); 3H-1,2-dithiole; 3-propyl-1,2-dithiolane; 3-acetyl-1,2-dithiolane; 1,2-dithiolane-4-carboxylic acid; 1,2-dithiolane-3-pentanol; 1,2,4-dithiazolidine; 1,2-dithiane; 1,2-dithiepane; 1,2-dithiocane; and 1,2-dithiolane-3,8-diol.
[0082] Photoinitiator
[0083] Photoinitiators refer to organic (carbon-containing) molecules that generate reactive species when exposed to radiation. In one embodiment, photoinitiators generate free radical reactive species, which are distinguished from, for example, cationic or anionic reactive species. Photoinitiators are well-known components used in the preparation of photopolymers, which can be used in photocurable coatings, adhesives, and dental restorative materials.
[0084] Type I photoinitiators are unimolecular free radical generators; upon absorption of UV-visible light, specific bonds within the initiator structure undergo homolytic cleavage to generate free radicals. Homolytic cleavage is the average breaking of bond pairs of electrons into free radical products. Examples of homolytic cleavage in several common classes of Type I photoinitiators are: benzoin ethers, benzyl ketals, α-dialkoxy-acetyl-phenones, α-hydroxy-alkylphenones, and acylphosphine oxides. Exemplary commercially available Type I photoinitiators available from, for example, BASF, BASF SE, Ludwigshafen, Germany include, but are not limited to, Irgacure TM 369、Irgacure TM 379、Irgacure TM 907、Darocur TM 1173, Irgacure TM 184. Irgacure TM 2959、Darocur TM 4265、Irgacure TM 2022, Irgacure TM 500、Irgacure TM 819, Irgacure TM 819-DW, Irgacure TM 2100, Lucirin TM TPO, Lucirin TM TPO-L、Irgacure TM 651、Darocur TM BP, Irgacure TM 250. Irgacure TM 270、Irgacure TM 290、Irgacure TM 784、Darocur TM MBF,Ivocerin,hand Irgacure TM754, lithium phenyl-2,4,6-trimethylbenzoylphosphinate, magnesium phenyl-2,4,6-trimethylbenzoylphosphinate, and sodium phenyl-2,4,6-trimethylbenzoylphosphinate.
[0085] In addition to the photoinitiator, the II type photoinitiator also requires a co-initiator (usually an alcohol or an amine), and the functional group can easily attract hydrogen. The II type photoinitiator absorbs UV-visible light to cause an excited electronic state in the photoinitiator, which will attract the hydrogen in the co-initiator and, in the process, split the bond pair of electrons. Benzophenone, thioxanthone and benzophenone type photoinitiators are the most common II type photoinitiators. Other examples of some common II type photoinitiators include riboflavin, eosin Y fluorescein, rose Bengal and camphorquinone. Once free radicals are generated, the polymerization mechanism is similar to any free radical polymerization process.
[0086] Optionally, the compositions of the present disclosure include at least one photoinitiator component, typically at a total concentration of less than 2 wt%, or less than 1.5 wt%, or less than 1 wt%, or less than 0.9 wt%, or less than 0.8 wt%, or less than 0.7 wt%, or less than 0.6 wt%, or less than 0.5 wt%, or less than 0.25 wt%, or less than 0.1 wt%, based on the total weight of the photoreactive compounds.
[0087] Optional Ingredients
[0088] The compositions of the present disclosure can contain optional ingredients, such as one, two or more optional ingredients. Exemplary optional ingredients are described herein.
[0089] In one aspect, coloring agents such as dyes may be included in the compositions of the present disclosure and corresponding cured products. Adding dyes can achieve the purpose of adjusting the preparation to the desired color. In one aspect, dyes are non-toxic, biocompatible dyes. Such dyes can be present in a concentration of about 2% by weight or less based on the gross weight of the composition. See, for example, PCT / US2016 / 059910, which is incorporated herein for its teachings on the use of dyes. In one embodiment, the dye is present in a concentration of about 0.1-0.3% by weight, which is the amount recommended by the FDA for the dye D&C Violet when present in an absorbable suture product. In one embodiment, the dye is present in a concentration of less than 0.5% by weight. In some cases, if the dye is present in too high a concentration, the dye may make the photopolymerizable composition of the present disclosure toxic.
[0090] In one aspect, a light reflective material component comprising a light reflective material can be suspended in the composition, wherein the light reflective material component modulates the light dose of the composition when compared to the light dose of a composition without the light reflective material. Suitable light reflective materials for optional inclusion in the compositions of the present disclosure are provided in U.S. Provisional Patent Application Serial No. 62 / 653,584, entitled Methods and Compositions for Photopolymerizable Additive Manufacturing, filed by applicant Poly-Med, Inc. on April 6, 2018 (with inventors MA Vaughn and P. Saini), which is incorporated herein in its entirety.
[0091] Suitable light reflective materials include light reflective materials that reflect UV light, visible light, or both. For example, the light reflective material can be or include a granular light reflective material having a size of less than 500 microns, or a size of less than 30 microns, or a size of less than 5 microns, or a size of less than 1 micron. The light reflective material can be shaped, for example, into a sphere, a cube, a cone, a cuboid, a cylinder, a pyramid, a prism, a polyhedron, or an irregular shape, or a mixture thereof. In one aspect, the light reflective material has a smooth surface.
[0092] In one aspect, the light reflective material may include inorganic solids including, but not limited to, titanium dioxide, zinc oxide, barium sulfate, tricalcium phosphate, dicalcium phosphate, monocalcium phosphate, dicalcium diphosphate, tricalcium phosphate, hydroxyapatite, apatite, and tetracalcium phosphate. In one aspect, the light reflective material may include organic compounds including aliphatic polymers and copolymers including, but not limited to, polyesters, polyurethanes, polyethers, polyanhydrides, polyamides, polycarbonates, polyketones, polyethylene, polypropylene, polyvinyl alcohol, polytetrafluoroethylene, polyvinyl chloride, polyimides, and polyhydroxyalkanoates or combinations thereof. In one aspect, the light reflective material may include organic compounds including aromatic polymers and copolymers including, but not limited to, polyesters, polyurethanes, polyethers, polyanhydrides, polyketones, polyamides, polycarbonates, and polyimides or combinations thereof. In one aspect, the light reflective material may include organic compounds including naturally derived polymers and derivatives including, but not limited to, cyclodextrin, starch, hyaluronic acid, deacetylated hyaluronic acid, chitosan, trehalose, cellobiose, maltotriose, maltohexaose, chitohexaose, agarose, chitin 50, amylose, dextran, heparin, xylan, pectin, galactan, glycosaminoglycan, dextran, aminated dextran, cellulose, hydroxyalkyl cellulose, carboxyalkyl cellulose, fucoidan, chondroitin sulfate, sulfated polysaccharide, mucopolysaccharide, gelatin, zein, collagen, alginic acid, agar, carrageenan, guar gum, gum arabic, gum ghatti, gum karaya, gum konjak, gum tamarind, gum tara, gum arabic ... In one aspect, the light reflective material may include crystalline organic compounds, including crystalline aliphatic and aromatic polymers. In one aspect, the light reflective material may include crystalline organic compounds, including crystalline natural source polymers and derivatives. In one aspect, the light reflective material may include crystalline amino acids and derivatives thereof. In one aspect, the light reflective material may include crystalline fatty acids and derivatives thereof, including but not limited to palmitic acid, ascorbyl palmitate, lauric acid, glyceryl monolaurate, myristic acid, and capric acid. In one aspect, the light reflective material may include crystalline peptides.
[0093] In one aspect, the compositions of the present disclosure may contain a diluent. The diluent may be reactive or non-reactive. Reactive diluents undergo photopolymerization when exposed to light (UV or visible light), while non-reactive diluents are inert to such light exposure. An exemplary reactive diluent is PEG-diacrylate (PEG-DA or PEGDA).
[0094] In one aspect, bioactive agents may be included in the compositions of the present disclosure and corresponding cured products. Examples of such bioactive agents include, but are not limited to, fibrosis inducing agents, antifungal agents, antibacterial agents and antibiotics, anti-inflammatory agents, anti-scarring agents, immunosuppressants, immunostimulants, disinfectants, anesthetics, antioxidants, cell / tissue growth promoting factors, anti-tumor agents, anti-cancer agents, and agents that support ECM integration.
[0095] Examples of fibrosis inducing agents include, but are not limited to, talcum powder, metallic beryllium and its oxides, copper, silk, silicon dioxide, crystalline silicates, talc, quartz dust, and ethanol; components of the extracellular matrix selected from fibronectin, collagen, fibrin, or fibrinogen; polymers selected from polylysine, poly(ethylene-co-vinyl acetate), chitosan, N-carboxybutyl chitosan, and RGD protein; vinyl chloride or vinyl chloride polymers; a polymer selected from cyanoacrylates and cross-linked poly(ethylene glycol)-methylated collagen. In the present invention, the present invention comprises an adhesive selected from the group consisting of white; inflammatory cytokines (such as TGFβ, PDGF, VEGF, bFGF, TNFα, NGF, GM-CSF, IGF-a, IL-1, IL-1β, IL-8, IL-6 and growth hormone); connective tissue growth factor (CTGF); bone morphogenetic protein (BMP) (such as BMP-2, BMP-3, BMP-4, BMP-5, BMP-6 or BMP-7); leptin, and bleomycin or its analogs or derivatives. Optionally, the device can further comprise a proliferation agent that stimulates cell proliferation. Examples of proliferative agents include: dexamethasone, isotretinoin (13-cis retinoic acid), 17-β-estradiol, estradiol, 1α, 25-dihydroxyvitamin D3, diethylstibesterol, cyclosporin A, L-NAME, all-trans retinoic acid (ATRA), and analogs and derivatives thereof (see, e.g., US2006 / 0240063, which is incorporated by reference in its entirety). Examples of antifungal agents include, but are not limited to, polyene antifungals, azole antifungals, and echinosporins. Examples of antibacterial agents and antibiotics include, but are not limited to, erythromycin, penicillin, cephalosporin, doxycycline, gentamicin, vancomycin, tobramycin, clindamycin, and mitomycin. Examples of anti-inflammatory agents include, but are not limited to, nonsteroidal anti-inflammatory drugs such as ketorolac, naproxen, diclofenac sodium, and flurbiprofen. Examples of anti-scarring agents include, but are not limited to, cell cycle inhibitors such as taxanes, immunomodulators such as serolimu or biolimus (see, e.g., US2005 / 0149158, which is incorporated by reference in its entirety). Examples of immunosuppressants include, but are not limited to, glucocorticoids, alkylating agents, antimetabolites, and drugs acting on immunophilic factors such as cyclosporine and tacrolimus. Examples of immunostimulants include, but are not limited to, interleukins, interferons, cytokines, toll-like receptor (TLR) agonists, cytokine receptor agonists, CD40 agonists, Fc receptor agonists, CpG-containing immunostimulatory nucleic acids, complement receptor agonists, or adjuvants. Examples of preservatives include, but are not limited to, chlorhexidine and tibenomyl iodide. Examples of anesthetics include, but are not limited to, lidocaine, mepivacaine, pyrocaine, bupivacaine, prilocalne, and etidocaine. Examples of antioxidants include, but are not limited to, antioxidant vitamins, carotenoids, and flavonoids.Examples of cell growth promoting factors include, but are not limited to, epidermal growth factor, human platelet-derived TGF-β, endothelial cell growth factor, thymocyte activating factor, platelet-derived growth factor, fibroblast growth factor, fibronectin or laminin. Examples of anti-tumor / anti-cancer agents include, but are not limited to, paclitaxel, carboplatin, miconazole, leflunomide and ciprofloxacin. Examples of agents that support ECM integration include, but are not limited to, gentamicin.
[0096] The compositions and corresponding cured articles of the present disclosure may contain a mixture of bioactive agents to achieve the desired effect. Thus, for example, an antibacterial agent and an anti-inflammatory agent may be combined in a single article to provide a combined effect.
[0097] Other optional components of the photopolymerizable composition are reactive diluents, non-reactive diluents, solvents, stabilizers, thixotropic materials, tracer materials, and conductive materials. When present, the stabilizer can be optionally selected from the group consisting of tocopherol, gallic acid, esters of gallic acid, butylated hydroxyanisole, and combinations thereof. By adding appropriate components, the photopolymerizable composition (e.g., article or piece) of the present disclosure can be colored due to the presence of a dye, or can have any other desired properties, such as at least a portion of the article having, but not limited to, fluorescent, radioactive, reflective, flexible, rigid, pliable, brittle, or a combination thereof.
[0098] In one aspect, the composition of the present disclosure comprising polyhv or polyΔ is polymerized in the absence of water, e.g., when water is not a diluent in the composition. Specifically, in one aspect, the composition forming a single network or a double network, or the single network or the double network itself, has a moisture (water) content of less than 2500 ppm, or less than 1000 ppm, or less than 500 ppm of water. In one aspect, the photocurable composition of the present disclosure that provides a single network is an anhydrous composition because it does not contain more than adventitious water. In one aspect, the photocurable and thermocurable composition of the present disclosure that provides a double network is an anhydrous composition because it does not contain more than adventitious water. The anhydrous composition of the present disclosure is not, for example, a hydrogel.
[0099] One challenge in forming formulations with ethylenically unsaturated compounds and thiol compounds is their tendency to polymerize when mixed at room temperature before applying a stimulus such as light or heat. Therefore, this may greatly limit the application of these formulations because their working time with constant viscosity may be very short. Specifically for additive manufacturing using vat photopolymerization, these formulations have the problem of viscosity changing over time. In the present disclosure, biocompatible stabilizers that can provide stability for at least 24 hours are outlined, which should be useful for addressing the working time of vat photopolymerization. In one aspect, one or more stabilizer compounds can be included in the compositions of the present disclosure and the corresponding cured products.
[0100] In one embodiment, the composition of poly(SH) or poly(EU) includes a stabilizer. The stabilizer can be contained in poly(SH), poly(EU) or a combination thereof. In one aspect, the stabilizer is an additional component. In another aspect, the stabilizer is contained as an addendum dissolved in a monomer, a diluent, a solvent or a combination thereof. In one aspect, the stabilizer is an antioxidant. In another aspect, the stabilizer is an acid. Preferably, the pKa of the acid stabilizer is between 1 and 5. In another aspect, the stabilizer is selected from phosphites and phosphonate compounds. In another aspect, the stabilizer can include antioxidants, acids, phosphites, phosphonates and combinations thereof. Examples of antioxidant stabilizers include, but are not limited to, hydroquinone, mono-tert-butyl hydroquinone (MTBHQ), 2,5-di-tert-butyl-hydroquinone (DTBHQ), p-methoxyphenol, butylated hydroxytoluene (BHT), butylated hydroxyanisole (BHA), 2,6-di-tert-butyl-p-cresol, 2,2-methylene-bis-(4-methyl-6-tert-butyl)phenol (MBETBP), p-tert-butylcatechol, 1,3,5-trimethyl-2,4,6-tris(3,5-di-tert-butyl-4-hydroxybenzyl)benzene (Anox 330TM, Irganox 1330TM), hydroxytoluene butyl ether, tocopherol (all isomers), esters of tocopherol, pyrogallol, lauryl gallate, esters of gallic acid, or a combination thereof. Examples of acid stabilizers may include, but are not limited to, phosphonic acid, phosphorous acid, oxalic acid, succinic acid, gallic acid, ascorbic acid, phenylphosphonic acid, or a combination thereof. Examples of phosphite and phosphonate stabilizers may include, but are not limited to, triphenyl phosphite, diphenyl isodecyl phosphite, diphenyl isooctyl phosphite, or a combination thereof. In one aspect, the stabilizer is soluble in poly(SH) and / or poly(EU) formulations. Preferably, the stabilizer is added at a concentration that achieves biocompatibility. Preferably, the biocompatible stabilizer includes tocopherol, gallic acid, esters of gallic acid, butylated hydroxyanisole, or a combination thereof. In one aspect, the stabilizer concentration is less than 100,000 ppm, more preferably less than 50,000 ppm, more preferably less than 15,000 ppm, more preferably less than 15,000 ppm, more preferably less than 5,000 ppm, more preferably less than 3,000 ppm, and even more preferably preferably less than 1,500 ppm.
[0101] Photopolymerization conditions
[0102] Photopolymerizable compounds polyhv (including polyEU and polySH) with photopolymerizable groups as described herein, and compositions of the present disclosure including such compounds, will polymerize after sufficient exposure to light of an appropriate wavelength, optionally in the presence of a photoinitiator, and further optionally in the presence of other components. The selection of appropriate wavelengths, exposure times, and the identity and amount of curing agents are selected in view of the identity and amount of the hv groups in the compounds and compositions, as is conventional in the art. Photopolymerization is sometimes referred to as radiation curing, in which case the photoinitiator may be referred to as a curing agent.
[0103] In one aspect, the photoinitiator component in the composition of the present disclosure includes a Type I photoinitiator. In one aspect, the photoinitiator component in the composition of the present disclosure includes a Type II photoinitiator. In one aspect, a combination of Type I and Type II photoinitiators are present in the composition of the present disclosure.
[0104] In any of the photopolymerizable compounds and compositions described herein, HV can be a carbon-carbon double bond, for example, a vinyl group. Exemplary vinyl groups are acrylate groups and methacrylate groups. Another exemplary carbon-carbon double bond is present in a norbornene group. In other aspects, photopolymerizable compounds having one or more HV groups photopolymerize when exposed to light having a wavelength of, for example, 300-450 nm, or 300-425 nm, or 350-450 nm, or 350-425 nm, or 365-405 nm, or 450-550 nm. In one embodiment, polyHV compounds and related compositions photopolymerize when exposed to UV radiation.
[0105] In any of the photopolymerizable compounds and compositions described herein, hv can be a thiol group. In further aspects, the photopolymerizable compound polySH having one or more SH groups photopolymerizes when exposed to actinic radiation, such as light having a wavelength of, for example, 300-450 nm, or 300-425 nm, or 350-450 nm, or 350-425 nm, or 365-405 nm, or 450-550 nm. In one embodiment, the polySH compounds and related compositions photopolymerize when exposed to UV radiation. In one embodiment, the polySH compounds and related compositions photopolymerize when exposed to visible radiation.
[0106] In one aspect, the present disclosure provides a composition comprising a compound having a plurality of photopolymerizable thiol groups and a compound having a plurality of photopolymerizable ethylenically unsaturated groups. The thiol groups and the ethylenically unsaturated groups react with each other in the presence of a photoinitiator and upon exposure to suitable actinic radiation. The actinic radiation may alternatively be referred to as light, and the composition may be referred to as photoreactive. This reaction may be referred to as photopolymerization or curing.
[0107] Suitable photoinitiators have been described elsewhere herein. In order for the photoinitiator to successfully cure the photoreactive composition, it is necessary that the absorption band of the photoinitiator overlaps with the emission spectrum of the light source used for curing. Optionally, the photopolymerizable composition disclosed herein comprises at least one photoinitiator that absorbs a wavelength of light in the range of about 10nm to about 770nm, or about 100nm to about 770nm, or about 200nm to about 770nm, and all wavelengths between the ranges. In one aspect, the photoinitiator component includes a photoinitiator that absorbs a wavelength of light equal to or greater than 300nm, up to about 770nm. In one aspect, the photoinitiator component includes a photoinitiator that absorbs a wavelength of light equal to or greater than 365nm, up to about 770nm. In one aspect, the photoinitiator component includes a photoinitiator that absorbs a wavelength of light equal to or greater than 375nm, up to about 770nm. In one aspect, the photoinitiator component includes a photoinitiator that absorbs a wavelength of light equal to or greater than 400nm, up to about 770nm. The photopolymerization conditions of the present disclosure will include exposing the photoreactive composition to a spectrum of wavelengths from an emission source that can and does provide a spectrum of desired wavelengths suitable for photopolymerization of the composition. The choice of wavelength will depend on the identity of the photoinitiator. Suppliers of commercially available photoinitiators specify appropriate wavelengths for specific photoinitiators.
[0108] Free radical generating photoinitiators can be used to achieve polymer curing according to the present disclosure. These photoinitiators can be used to cure mixtures of thiol-containing compounds and ethylenically unsaturated compounds, such as those disclosed herein. There are two types of free radical generating photoinitiators, designated as Type I and Type II photoinitiators, which can be used according to the present disclosure and are described elsewhere herein.
[0109] The photopolymerizable compositions disclosed herein are prepared by combining the desired components (typically with stirring) to obtain a uniform composition. A homogenizer can be used to mix the desired components. For example, the compositions disclosed herein can be prepared by combining ingredients (such as those determined above). Optionally, the desired components can include a dispersant to help suspend. The listed components can optionally be heated before mixing. The listed components can optionally be placed under vacuum to remove bubbles.
[0110] In one aspect, the present disclosure provides a composition comprising a first organic compound (polySH) having a plurality of thiol groups (SH), a second organic compound (polyEU) having a plurality of ethylenically unsaturated groups (EU), and a photoinitiator. The relative amounts of polySH and polyEU in the composition can be described in terms of an equivalent ratio of SH to EU, X:Y, wherein X represents the equivalent of SH, Y represents the equivalent of EU, and the sum of X and Y is 100. In one aspect, X is in the range of 25-75 and Y is in the range of 75-25, and the sum of X and Y is 100. In one aspect, X is in the range of 30 to 70 and Y is in the range of 70 to 30, and the sum of X and Y is 100. In one aspect, X is in the range of 40 to 60 and Y is in the range of 60 to 40, and the sum of X and Y is 100. In one aspect, X is in the range of 45 to 55 and Y is in the range of 55 to 45, and the sum of X and Y is 100. In one aspect, the equivalent amount of X is approximately equal to the equivalent amount of Y.
[0111] Thermal reaction conditions
[0112] As discussed herein, the compositions of the present disclosure may contain polyΔ1 and polyΔ2 that are reactive with each other when exposed to elevated temperatures. The specific elevated temperature and the time necessary to achieve a reaction between polyΔ1 and polyΔ2 at that specific elevated temperature will depend on the specific identities of Δ1 and Δ2. For many reactions between nucleophiles and electrophiles, a temperature of about 100°C for 30 minutes to 5 hours is sufficient.
[0113] In one aspect, the present disclosure provides a composition comprising a first organic compound (polyhv) having a plurality of photopolymerizable groups (hv), a photoinitiator, a second organic compound (polyΔ1) having a plurality of reactive groups Δ1, and a third organic compound (polyΔ2) having a plurality of reactive groups Δ2, wherein Δ1 and Δ2 react when in contact and exposed to a temperature greater than about 50°C. The relative amounts of polyΔ1 and polyΔ2 in the composition can be described in terms of an equivalent ratio of Δ1 to Δ2, X:Y, wherein X represents an equivalent of Δ1, Y represents an equivalent of Δ2, and the sum of X and Y is 100. In one aspect, X is in the range of 25-75, Y is in the range of 75-25, and the sum of X and Y is 100. In one aspect, X is in the range of 30 to 70, Y is in the range of 70 to 30, and the sum of X and Y is 100. In one aspect, X is in the range of 40 to 60 and Y is in the range of 60 to 40, and the sum of X and Y is 100. In one aspect, X is in the range of 45 to 55 and Y is in the range of 55 to 45, and the sum of X and Y is 100. In one aspect, the equivalents of X are approximately equal to the equivalents of Y.
[0114] To expose the composition to elevated temperatures, the composition can be placed in an oven. Alternatively, a heat lamp can be directed at the composition, wherein the headlights provide infrared radiation that will heat the composition.
[0115] Additive Manufacturing
[0116] The methods disclosed herein include methods for using curable compositions to make articles, particularly non-toxic and biodegradable articles. For example, the compositions disclosed herein can be used as curable inks or resins in 3-D printing methods. For example, the curable compositions disclosed herein can be used as curable inks or resins in barrel polymerization processes for 3-D printing. Exemplary barrel polymerization processes include stereolithography (SLA, also known as SL), digital light processing (DLPTM; Texas Instrument), daylight polymer printing (DPP), carbon digital light synthesis (Carbon DLS TM ; Carbon, Inc.) and Continuous Liquid Interface Production (CLIP TM ; Carbon, Inc.). Other suitable methods for additive manufacturing of articles using the curable compositions of the present disclosure include binder jetting, material jetting, material extrusion, computational axial lithography, and 2-photon polymerization printing. The present disclosure provides for the use of the curable compositions as disclosed herein in any of the mentioned 3D printing methods.
[0117] Thus, in one aspect, the present disclosure provides a method for vat polymerization, such as SLA printing of articles, comprising exposing a photopolymerizable composition for a period of time, the photopolymerizable composition comprising at least one photopolymerizable composition as disclosed herein comprising: at least one photoinitiator component (typically at a total concentration of less than 1.0 wt %). Any photopolymerizable composition disclosed herein can be used in the method of SLA printing articles. For example, in addition to polyΔ1 and polyΔ2, the composition may contain polyhv. As another example, the composition may contain polyEU and polySH. Optionally, the photopolymerizable composition may contain a reactive diluent or a non-reactive diluent. A reactive diluent is a diluent that participates in a polymerization reaction, for example, a reactive diluent polymerizes with, for example, a macromonomer. The photopolymerizable composition of the present disclosure may contain a stabilizer, such as a free radical stabilizer.
[0118] The method for printing an article by SLA according to the present disclosure may include a secondary curing step, which includes curing the printed article using thermal energy. The secondary curing step includes exposing at least a portion of the printed article to thermal energy to cause a second thermally induced polymerization reaction to occur in at least a portion of the printed article. For example, a portion or all of the article may be exposed to a temperature of about 100° C. for about 30 minutes to 5 hours. The secondary curing step may be used to change the properties of the printed article.
[0119] The method for printing an article by SLA according to the present disclosure may include pre-processing and / or post-processing of the printed article. For example, the printed article may be rinsed after printing, before or after a thermal curing step.
[0120] A printed article is an article obtained after the 3-D printing phase is completed. A printed article may be a structure or a portion of a structure. A printed article may be in the form of a film, such as a coating printed on a surface. As used herein, the term printing is used to refer to contacting a polymer composition with a surface and further polymerizing the polymer composition. Printing may involve contacting a polymer composition with a surface, and then exposing the surface to UV and / or visible light to further polymerize the polymer composition. The surface contacted by the polymer composition may be any surface comprising a polymeric layer of a polymer composition. As previously mentioned, the printed article may undergo a second curing step by being exposed to an elevated temperature.
[0121] The printed article may or may not contain residual amounts of components of the curable composition. For example, the printed article may include a diluent or a photopolymerization diluent or a photoinitiator. In one aspect, the printed article or curable composition may have an additive. The additive may include a thixotropic material, a colorant, a tracer material, or a conductive material. For example, the additive may be a dye. The printed article may be colored due to the presence of a dye, or may have any desired properties, such as at least a portion of the article having, but not limited to, fluorescence, radioactivity, reflectivity, flexibility, rigidity, pliability, fragility, or a combination thereof.
[0122] In a common barrel printing process, the level to which the build platform descends from the top of the resin barrel is the layer thickness. Actinic radiation is directed into the composition and this light causes photopolymerization (photocuring) of the composition. The build platform continues to move downward and additional layers are built on top of the previous layer. After completion, the excess resin in the barrel can be drained and the printed article collected. This printed article can undergo additional processing. For example, the printed article can be washed to remove excess resin. As another example, particularly in the case where the article contains polyΔ1 and polyΔ2, the printed article can be exposed to thermal energy to cause thermal curing to occur.
[0123] The method of forming an article by vat polymerization can include directing actinic radiation into a vat of a photopolymerizable composition comprising monomers or macromers capable of polymerization, such as monomers or macromers having functional groups capable of photopolymerization to form oligomers and / or polymers, such as the polyhv compounds disclosed herein.
[0124] In one aspect, barrel polymerization, such as using SLA, is the use of a photopolymerizable composition to print an article, and directing actinic radiation to the barrel of the composition at a wavelength of light of about 10 nm to about 1 mm. As used herein, UV radiation has a wavelength of about 10-400 nm, while visible radiation has a wavelength of 390-770 nm, and IR radiation has a wavelength of 770 nm-1 mm. In one aspect, the actinic radiation consists of one or more wavelengths and / or one or more radiation sources. In one aspect, the photopolymerizable composition may include a light reflective material component that causes photopolymerization to occur in a shorter exposure time under the same polymerization conditions than in the absence of the light reflective material component. Optionally, if the curable composition contains thermally reactive components polyΔ1 and polyΔ2, a thermal curing formation will be performed before, during, or after the photopolymerization process. Optionally, if the curable composition contains thermally reactive components polyΔ1 and polyΔ2, a thermal curing process will be performed after the photopolymerization formation.
[0125] In one aspect, the present disclosure provides a method for printing an article using barrel polymerization, such as SLA printing (in an apparatus suitable for printing by SLA). The method includes providing a barrel containing a curable composition as disclosed herein, the curable composition comprising at least one photoinitiator that absorbs at a wavelength of light from about 10nm to about 770nm. In one aspect, the photoinitiator absorbs at a wavelength of light greater than or equal to 300nm. In one aspect, the photoinitiator absorbs at a wavelength of light greater than or equal to 365nm. In one aspect, the photoinitiator absorbs at a wavelength of light greater than or equal to 375nm. In one aspect, the photoinitiator absorbs at a wavelength of light greater than or equal to 400nm. The photoinitiator in the curable composition is at least one photoinitiator component, the photoinitiator component including a photoinitiator that is a Type I, Type II, cationic photoinitiator, or a combination thereof.
[0126] In one aspect, the present disclosure provides a method of printing an article by vat polymerization, for example, using SLA in an apparatus for printing by SLA, wherein the method comprises photopolymerizing or curing a photopolymerizable composition at a depth of less than 150 microns. In one aspect, a method disclosed herein comprises photopolymerizing or curing a photopolymerizable composition at a depth of about 5 microns to about 50 microns and all depths therebetween.
[0127] In one aspect, the present disclosure provides a method for printing an article by barrel polymerization, for example, using SLA in an apparatus for printing by SLA, wherein the method includes a photopolymerizable composition comprising a light reflective material component, the light reflective material component including a light reflective material that is absorbable under physiological conditions. In one aspect, the light reflective material component includes a light reflective material that is compatible with biological organisms. In one aspect, the light reflective material component includes a light reflective material polymerized with at least one of the following: a photopolymerizable macromer, a diluent, a light reflective material, or a combination thereof.
[0128] In one aspect, the present disclosure provides an additive manufacturing method comprising: (a) providing a barrel containing a first composition comprising polyEU and polySH as disclosed herein; (b) directing actinic radiation from a light source into the first composition in the barrel, wherein the actinic radiation is effective to induce polymerization of the components of the composition to form a second composition; (c) forming a solid article comprising the second composition. Step (c) can be accomplished by repeatedly directing actinic radiation to the first composition in the barrel, particularly as the build platform moves. The second composition will be a photopolymerization product of polyEU and polySH or a photopolymerization product comprising polyEU and polySH.
[0129] In one aspect, the present disclosure provides an additive manufacturing method comprising: (a) providing a barrel containing a first composition containing polyhv, polyΔ1, and polyΔ2 as disclosed herein; (b) directing actinic radiation from a light source into the first composition in the barrel, wherein the actinic radiation effectively induces polymerization of the photocurable components of the first composition to form a second composition comprising a photochemically cured composition; and (c) applying thermal energy to the second composition comprising a photochemically cured composition to form a third composition comprising a photochemically cured composition and a thermally cured composition. The second composition will be a photopolymerization product of polyhv or a photopolymerization product comprising polyhv. The third composition will be or comprise: a double network of a photopolymerization product of polyΔ1 and polyΔ2 and a photopolymerization product of polyhv combined with the thermally induced polymerization product.
[0130] In one aspect, the present disclosure provides a method for manufacturing an article by 2-photon polymerization printing, comprising curing a curable composition as disclosed herein to form an article. In one aspect, the present disclosure provides a method for manufacturing an article by computer axial lithography, comprising curing a curable composition as disclosed herein to form an article. In one aspect, the present disclosure provides a method for manufacturing an article by material extrusion, the method comprising curing a curable composition as disclosed herein to form an article. In one aspect, the present disclosure provides a method for manufacturing an article by material jetting, comprising curing a curable composition as disclosed herein to form an article. In one aspect, the present disclosure provides a method for manufacturing an article by adhesive jetting, comprising curing a curable composition as disclosed herein to form an article. In one aspect, the present disclosure provides a method for manufacturing an article by continuous optical interface production (CLIP), comprising curing a curable composition as disclosed herein to form an article. In one aspect, the present disclosure provides a method for manufacturing an article by barrel polymerization, comprising curing a curable composition as disclosed herein to form an article.
[0131] Cured composition
[0132] The present disclosure includes articles, otherwise referred to herein as printed articles or solid articles, which can be made from the compositions disclosed herein by the methods disclosed herein. In one aspect, the article can be a medical device. In one aspect, the article can be part of a medical device. In one aspect, the article can be porous. In one aspect, the article can be biodegradable under physiological conditions. In one aspect, a biodegradable article can have a degradation time of about three days to about five years. In one aspect, the article may not be biodegradable. In one aspect, a portion of the article can be biodegradable, while a second portion can be non-biodegradable, or have a degradation time that is different from the degradation time of the first portion or the remainder of the article.
[0133] As mentioned elsewhere, in one aspect, the cured composition does not contain any appreciable amount of water. For example, in some aspects, the cured composition contains less than 2500 ppm of water, or less than 1000 ppm of water, or less than 500 ppm of water.
[0134] In one aspect, the solidified composition will degrade in water or degrade when exposed to aqueous conditions.Therefore, in one aspect, the solidified composition can be biodegradable, which may be particularly useful when the solidified composition is used to form a biodegradable implantable medical device.In one aspect, the solidified composition degrades to form a granular material under aqueous conditions, rather than, for example, forming a swollen material, that is, absorbing water and being in a swollen state.For example, when the solidified composition is placed in a degradation medium comprising water in pH 7.0 to 7.4 phosphate buffer or in phosphate buffered saline, the solidified composition will be dissolved in the degradation medium.After dissolving, make the solidified composition gross weight account for greater than 50% by weight, or greater than 60% by weight, or greater than 70% by weight, or greater than 80% by weight, or greater than 90% by weight dissolved in the degradation medium, the undissolved material will have a specific form rather than a swollen form.
[0135] In one aspect, the solidified compositions of the present disclosure exhibit desired low swelling properties when placed in an aqueous medium. Swelling may be a serious problem when the solidified compositions are in contact with aqueous media for a long time. For example, when the solidified compositions are a component or all of a biodegradable implantable medical device and the device is implanted in a patient, the device may degrade (which is desired) and swell (which may be undesirable). Swelling may be a particular problem at the end of implant degradation, i.e., after most of the implant has degraded. However, swelling problems, particularly late swelling that may be observed after most of the implant has degraded (i.e., greater than 50% weight loss, or greater than 60% weight loss, or greater than 70% weight loss, or greater than 80% weight loss or greater than 90% weight loss), can be alleviated by using the solidified compositions of the present disclosure.
[0136] Following are some exemplary embodiments of the present disclosure.
[0137] 1) A composition comprising a first organic compound (polySH) having a plurality of thiol groups (SH), a second organic compound (polyEU) having a plurality of ethylenically unsaturated groups (EU), and a photoinitiator. A stabilizer may optionally be present in the composition, wherein the stabilizer may optionally be selected from the group consisting of: tocopherol, gallic acid, esters of gallic acid, butylated hydroxyanisole; and combinations thereof.
[0138] 2) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as embodiments 3-27, wherein the composition has an SH to EU equivalent ratio of X:Y, wherein X is in the range of 25-75 and Y is in the range of 75-25, and the sum of X and Y is 100.
[0139] 3) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as embodiment 2, wherein polySH is water-soluble.
[0140] 4) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as embodiment 2 or 3, wherein the polySH is bioabsorbable.
[0141] 5) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as embodiment 2 or 3 or 4, wherein polySH is a macromonomer.
[0142] 6) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as embodiment 2 or 3 or 4, wherein polySH is a macromonomer with a molecular weight greater than 1,000 g / mol.
[0143] 7) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as embodiment 2 or 3 or 4, wherein the molecular weight of polySH is less than 500 g / mol.
[0144] 8) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as any one of embodiments 2-7, wherein polyEU is water-soluble.
[0145] 9) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as any one of embodiments 2-8, wherein polyEU is bioabsorbable.
[0146] 10) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as embodiments 2-9, wherein EU of PolyEU is acrylate.
[0147] 11) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as embodiments 2-9, wherein EU of PolyEU is methacrylate.
[0148] 12) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as embodiments 2-9, wherein EU of PolyEU is norbornene.
[0149] 13) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as embodiments 2-7, wherein polyEU is a macromonomer.
[0150] 14) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as embodiments 2-7, wherein polyEU is a macromonomer with a molecular weight greater than 1,000 g / mol.
[0151] 15) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as embodiments 2-14, wherein at least one of polySH and polyEU also has multiple carbonyl groups, wherein optionally polyEU has multiple carbonyl groups, or wherein optionally polySH and polyEU each have multiple carbonyl groups.
[0152] 16) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as embodiments 2-15, wherein at least one of polySH and polyEU also has multiple ester groups, wherein optionally polyEU has multiple ester groups, or wherein optionally polySH and polyEU each have multiple ester groups.
[0153] 17) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, for example embodiments 2-15, wherein at least one of polyEU and polySH also has multiple ester groups and multiple carbonate groups, wherein optionally polyEU also has multiple ester groups and multiple carbonate groups, or wherein optionally both polyEU and polySH also have multiple ester groups and multiple carbonate groups.
[0154] 18) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, for example embodiments 2-15, wherein at least one of polySH and polyEU also has multiple ester groups and multiple carbamate groups, wherein optionally polyEU also has multiple ester groups and multiple carbamate groups, or wherein optionally both polyEU and polySH also have multiple ester groups and multiple carbamate groups.
[0155] 19) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, for example embodiments 2-15, wherein at least one of polySH and polyEU also has multiple carbonate groups and multiple carbamate groups, wherein optionally polyEU also has multiple carbonate groups and multiple carbamate groups, or wherein optionally both polyEU and polySH also have multiple carbonate groups and multiple carbamate groups.
[0156] 20) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as embodiments 2-19, wherein the multiple SHs of the polySH are selected from 2, 3 and 4.
[0157] 21) A composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as embodiments 2-20, wherein the multiple EUs of the PolyEU are selected from 2, 3 and 4.
[0158] 22) The composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as embodiments 2-21, which does not contain volatile substances with a boiling point below 110°C.
[0159] 23) The composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as embodiments 2-22, which is anhydrous.
[0160] 24) The composition according to embodiment 1 or any embodiment of embodiment 1 as disclosed herein, such as embodiments 2-23, which is fluid at room temperature of about 18°C to about 22°C.
[0161] 25) A composition comprising a photochemically cured reaction product of the composition according to any one of embodiments 1 to 24.
[0162] 26) The composition according to embodiment 25 is bioabsorbable.
[0163] 27) A composition according to embodiment 25 which is solid at 50°C.
[0164] 28) An additive manufacturing method, comprising:
[0165] a. providing a barrel containing a composition according to any one of embodiments 1-24;
[0166] b. directing actinic radiation from a light source to the first composition in the barrel, wherein the actinic radiation is effective to induce polymerization of the components of the composition to form a second composition; and
[0167] c. forming a solid article comprising the second composition.
[0168] 29) A composition comprising a first organic compound (polyhv) having a plurality of photopolymerizable groups (hv), a photoinitiator, a second organic compound (polyΔ1) having a plurality of reactive groups Δ1, and a third organic compound (polyΔ2) having a plurality of reactive groups Δ2, wherein Δ1 and Δ2 react after contact and exposure to a temperature greater than 50°C.
[0169] 30) A composition according to embodiment 29 or any of embodiment 29, wherein the polyhv is bioabsorbable.
[0170] 31) A composition according to embodiment 29 or any embodiment of embodiment 29, for example embodiment 30, wherein ppolyhv is a macromonomer.
[0171] 32) A composition according to embodiment 29 or any embodiment of embodiment 29, such as embodiment 30 or 31, wherein polyhv is a macromonomer with a molecular weight greater than 1,000 g / mol.
[0172] 33) A composition according to embodiment 29 or any embodiment of embodiment 29, such as embodiment 30 or 31, wherein the molecular weight of polyhv is less than 500 g / mol.
[0173] 34) A composition according to embodiment 29 or any embodiment of embodiment 29, such as embodiment 30 or 31, wherein the polyhv is water soluble.
[0174] 35) A composition according to embodiment 29 or any embodiment of embodiment 29, such as embodiments 30 to 34, wherein polyhv is polyEU selected from acrylates and methacrylates.
[0175] 36) A composition according to embodiment 29 or any embodiment of embodiment 29, such as embodiments 30 to 34, wherein hv of polyhv is norbornene.
[0176] 37) A composition according to embodiment 29 or any embodiment of embodiment 29, such as embodiments 30 to 36, wherein Δ1 is a nucleophile and Δ2 is an electrophile.
[0177] 38) A composition according to embodiment 29 or any embodiment of embodiment 29, such as embodiments 30 to 36, wherein Δ1 is selected from hydroxyl and amino.
[0178] 39) A composition according to embodiment 29 or any embodiment of embodiment 29, such as embodiments 30 to 36, wherein Δ2 is selected from epoxides and isocyanates.
[0179] 40) A composition according to embodiment 29 or any embodiment of embodiment 29, for example embodiments 30 to 39, wherein at least one of polyhv, polyΔ1 and polyΔ2 also has multiple carbonyl groups, wherein optionally polyhv has multiple carbonyl groups, or wherein optionally at least one of polyΔ1 and polyΔ2 and polyhv have multiple carbonyl groups.
[0180] 41) A composition according to embodiment 29 or any embodiment of embodiment 29, for example embodiments 30 to 39, wherein at least one of polyhv, polyΔ1 and polyΔ2 also has multiple ester groups, wherein optionally polyhv has multiple ester groups, or wherein optionally at least one of polyΔ1 and polyΔ2 and polyhv have multiple ester groups.
[0181] 42) A composition according to embodiment 29 or any embodiment of embodiment 29, for example embodiments 30 to 39, wherein at least one of polyhv, polyΔ1 and polyΔ2 also has multiple ester groups and multiple carbonate groups, wherein optionally polyhv has multiple ester groups and multiple carbonate groups at the same time, or wherein optionally at least one of polyΔ1 and polyΔ2 and polyhv have multiple ester groups and multiple carbonate groups at the same time.
[0182] 43) A composition according to embodiment 29 or any embodiment of embodiment 29, for example embodiments 30 to 39, wherein at least one of polyhv, polyΔ1 and polyΔ2 also has multiple ester groups and multiple urethane groups, wherein optionally polyhv has multiple ester groups and multiple urethane groups at the same time, or wherein optionally at least one of polyΔ1 and polyΔ2 and polyhv have multiple ester groups and multiple urethane groups at the same time.
[0183] 44) A composition according to embodiment 29 or any embodiment of embodiment 29, for example embodiments 30 to 39, wherein at least one of polyhv, polyΔ1 and polyΔ2 also has multiple carbonate groups and multiple urethane groups, wherein optionally polyhv has multiple carbonate groups and multiple urethane groups at the same time, or wherein optionally at least one of polyΔ1 and polyΔ2 and polyhv have multiple carbonate groups and multiple urethane groups at the same time.
[0184] 45) A composition according to embodiment 29 or any embodiment of embodiment 29, such as embodiments 30 to 44, wherein the multiple hv of the polyhv is selected from 2, 3 and 4.
[0185] 46) A composition according to embodiment 29 or any embodiment of embodiment 29, such as embodiments 30 to 44, wherein the multiple Δ1 of polyΔ1 is selected from 2, 3 and 4.
[0186] 47) A composition according to embodiment 29 or any embodiment of embodiment 29, such as embodiments 30 to 44, wherein the multiple Δ2 of the polyΔ2 is selected from 2, 3 and 4.
[0187] 48) The composition according to embodiment 29 or any embodiment of embodiment 29, such as embodiments 30 to 47, which does not contain volatile substances with a boiling point below 110°C.
[0188] 49) The composition according to embodiment 29 or any embodiment of embodiment 29, such as embodiments 30 to 47, which is anhydrous.
[0189] 50) The composition according to embodiment 29 or any embodiment of embodiment 29, such as embodiments 30 to 47, which is fluid at a temperature of about 18°C to about 22°C.
[0190] 51) A composition comprising a photochemically cured reaction product and a thermally cured reaction product of the composition according to any one of embodiments 29-50.
[0191] 52) The composition according to embodiment 51 is bioabsorbable.
[0192] 53) A composition according to embodiment 51 which is solid at 50°C.
[0193] 54) An additive manufacturing method, comprising:
[0194] a. providing a barrel containing a first composition according to any one of embodiments 29-50;
[0195] b. directing actinic radiation from a light source into the first composition in the barrel, wherein the actinic radiation is effective to induce polymerization of the components of the first composition to form a second composition comprising a photochemically curable composition; and
[0196] c. applying thermal energy to the second composition comprising a photochemically curable composition to form a third composition comprising a photochemically curable composition and a thermally curable composition.
[0197] The present disclosure has been broadly and generally described herein. Each narrower class and subclass grouping falling within the scope of the overall disclosure also forms a part of the present disclosure. This includes a general description of the present disclosure with a proviso or negative limitation removing any subject matter from the genus, regardless of whether the removed material is specifically recited herein.
[0198] It will also be understood that, as used herein and in the appended claims, the singular forms "a", "an", and "the" include plural references, unless the context clearly dictates otherwise, the term "X and / or Y" means "X", "Y", or "X" and "Y", and the letter "s" following a noun refers to both the plural and singular forms of that noun. Additionally, where features or aspects of the disclosure are described in terms of Markush groups, it is intended, and those skilled in the art will recognize, that the disclosure encompasses and is thereby also described in terms of any individual member and any subgroup of the Markush group, and the applicant reserves the right to amend the application or the claims to specifically refer to any individual member or any subgroup of members of the Markush group.
[0199] The following examples are offered by way of illustration and not limitation. Chemicals were obtained from commercial sources such as MilliporeSigma (St. Louis, MO, USA).
[0200] Example
[0201] Example 1
[0202] Hydroxyl terminated precursor polymer
[0203] In one aspect, the present disclosure provides a composition containing at least one of the compounds represented as polyhv, polySH, polyEU, polyΔ1, and polyΔ2. Optionally, each of these compounds can be made from a precursor polymer having a hydroxyl group instead of a hv or SH or EU or Δ1 or Δ2 group, wherein the hv, SH, EU, Δ1 or Δ2 group is optionally joined to the precursor polymer by a suitable linker. This example illustrates the preparation of an exemplary hydroxyl-containing precursor polymer.
[0204] Table 1 identifies 16 precursor polymers, which are uniquely labeled 3DP 1 to 3DP 16, which can generally be described as compounds having or including the general formula CC-[arm-OH] according to the present disclosure. The term arm-OH refers to an arm terminating in a hydroxyl (OH) group (i.e., having a hydroxyl terminal group).
[0205] When the precursor polymer comprises a compound comprising the formula CC-[(A)-(B)], that is, when the arms are formed from residues of monomers from Group A (any one or more of propylene carbonate and ε-caprolactone) which are proximal (adjacent) to the central core and residues of monomers from Group B (any one or more of glycolide, lactide and p-dioxanone) which are distal (farthest away) to the central core, such a precursor polymer can be prepared by reacting a functionalized central core (also referred to herein as an initiator) with one or more monomers from Group A, followed by reacting the reaction product (referred to herein as a precursor prepolymer) with one or more monomers from Group B. The result is a central core bonded to one or more arms, each of which is hydroxyl terminated and has the formula -(A)-(B)-OH. The preparation of such a precursor polymer is illustrated in Example 1A below, where the central core is trifunctional and the functionalized central core / initiator is provided by trimethylolpropane.
[0206] Example 1A - Preparation of triaxial 3DP-6 precursor polymer.
[0207] Trimethylolpropane (0.6 mol) was used as the initiator and stannous octoate (7.0 x 10 -5 Propylene carbonate (1.4 mol) and ε-caprolactone (1.4 mol) were copolymerized at 130°C for 72 hours using 1.4 mol of propylene carbonate as a catalyst to provide a polymer precursor. Glycolide (1.1 mol) and additional stannous octoate (2.1 x 10 -4 mol) was combined with the polymer precursor for 3 hours to provide a precursor polymer having polyglycolide grafted at the end of the polymer precursor. The amorphous liquid precursor polymer thus obtained was devolatile and passed through 1 H NMR spectroscopy, rheometer (at a shear rate of 105 s -1 The product was characterized by differential scanning calorimetry (Tg = -45°C) and gel permeation chromatography (Mn = 1884 Da, PDI = 1.80).
[0208] When the precursor polymer comprises a compound comprising the formula CC-[(B)-(A)], i.e., when the residues of monomers from Group B (glycolide, lactide, and p-dioxanone) are proximal (adjacent) to the central core, and the residues of monomers from Group A (propylene carbonate and caprolactone) are distal (farthest from) the central core, such a precursor polymer can be prepared by reacting the functionalized central core with one or more monomers from Group B, followed by reacting the reaction product with one or more monomers from Group A. The result is a central core bonded to one or more arms, each arm being hydroxyl terminated and having the formula -(B)-(A)-OH. The preparation of such a precursor polymer is illustrated in Example 1B below, wherein the central core is trifunctional and the functionalized central core is provided by trimethylolpropane.
[0209] Example 1B - Preparation of Triaxial 3DP-4 Precursor Polymer.
[0210] In the first step, glycolide (1.1 mol) was reacted with trimethylolpropane (0.6 mol) as an initiator and stannous octoate (7 x 10 -5 mol) for 3 hours to provide a polymer precursor. After the first step, more stannous octoate (2 x 10 -4 mol) and reacted at 130°C for 72 hours, and a mixture of equimolar amounts of propylene carbonate (1.4 mol) and ε-caprolactone (1.4 mol) was copolymerized to the ends of the polymer precursor. The resulting amorphous liquid was devolatile and 1 H NMR spectroscopy, rheometer (at a shear rate of 105 s -1 The product was characterized by differential scanning calorimetry (Tg = -45°C) and gel permeation chromatography (Mn = 1909 Da, PDI = 1.83).
[0211] Following the procedures outlined in Examples 1A and 1B, additional polyester precursor polymers were synthesized as described in Table 1. All linear samples were synthesized using 1,3-propanediol as the difunctional initiator, all trifunctional prepolymers were prepared using trimethylolpropane, and the 4-arm block copolyester compositions were initiated by pentaerythritol as the tetrafunctional initiator. In Table 1, M / I refers to the total number of moles of monomers used to make the arms (M) divided by the number of moles of initiator (also referred to as the functionalized central core) for each copolyester identified in Table 1 (I). Also in Table 1, M / C refers to the total number of moles of monomers used to make the arms (M) divided by the total number of moles of catalyst used to make each copolyester prepolymer identified in Table 1 (C). Each precursor polymer of Table 1 contains a B region, characterized by the column titled G / L / pD (which is short for glycolide / lactide / p-dioxanone segment), and which can be close to the central core (in which case the location of the B region is identified as being at the center of the precursor polymer) or which is far from the central core (in which case the location of the B region is identified as being at the end of the precursor polymer, and in which case the B region terminates at a hydroxyl group).
[0212] For selected precursor polymers prepared as exemplified in Example 1, selected molecular weight results obtained by gel permeation chromatography (GPC) are provided in Table 2. In Table 2, Mn refers to number average molecular weight, Mw refers to weight average molecular weight, PDI refers to polydispersity (i.e., Mw / Mn), and Da refers to Daltons.
[0213]
[0214]
[0215] Table 2: 3DP molecular weight (Mn and Mw) and polydispersity index (PDI)
[0216]
[0217] Example 2
[0218] Preparation of Methacrylated Compounds of Exemplary Polymers of the Disclosure of Formula PolyEU
[0219] Table 3 identifies eight EU-functionalized precursor polymers, individually labeled 3DP 4m (m represents methacrylate, which is an exemplary ethylenically unsaturated (EU) group) through 3DP 7m and 3DP 9m through 3DP 12m, which can be collectively described as compounds having or including the general formula CC-[arm-EU] according to the present disclosure. The designation Arm-EU refers to an arm terminating in a photoreactive ethylenically unsaturated group such as an acrylate ("a") or methacrylate ("m") group.
[0220] The methacrylated polymers of Table 3 were prepared from the corresponding precursor polymers of Table 1, ie, 3DP 4m was prepared from 3DP 4, 3DP 5m was prepared from 3DP 5, and so on.
[0221] 3DP 6 is methacrylated to form 3DP 6m
[0222] The 3DP 6 precursor polymer (0.131 mol) was reacted with excess methacrylic anhydride in the presence of 3-tert-2-butyl-4-hydroxyanisole (6.724 x 10-4 mol) at 120°C for 24 hours. Residual methacrylic anhydride and methacrylic acid by-product were removed from the crude polymer using a rotary evaporator. The resulting amorphous liquid polymer was used 1 The 3DP formulations were characterized by H NMR spectroscopy, rheometer (viscosity 16,400 cP at shear rate 105 s-1), differential scanning calorimetry (Tg = -38 ° C.), and gel permeation chromatography (Mn = 2162 Da, PDI = 1.75). Each 3DP formulation was methacrylated according to the procedure outlined above. The composition and molecular weight results are summarized in Table 3, and the dynamic viscosity is reported in Table 4. In Table 3, for 3DP 5m, the 40.15 in the TMC column is the total mole % of TMC plus 1,3-propylene glycol used to prepare 3DP 5m.
[0223] Table 3: Composition and molecular weight results of methacrylated 3DP formulations
[0224]
[0225] Table 4: Dynamic viscosity of methacrylated 3DP polymers
[0226]
[0227] Example 3
[0228] Preparation of Thiolated Compounds of Exemplary Polymers of the Present Disclosure of Formula PolySH
[0229] In a nitrogen environment, 3DP 6 (51.3 g; 0.0665 mole; see Table 1), thiolactic acid (17.243 mL; 20.623 g; 0.1943 mole) and dichloromethane (DCM) (200 mL) were loaded into a 500 mL 3-neck round bottom flask equipped with a mechanical stirrer and an addition funnel. The contents of the reaction vessel were stirred at 200 rpm and an ice bath was used to cool the reaction vessel. Separately, N, N'-dicyclohexylcarbodiimide (DCC) (44.5 g, 0.2157 mole) was dissolved in 200 mL DCM. Then, over a period of 30 minutes, an addition funnel was used to dropwise add the DCC in the DCM solution into the reaction vessel. After the addition of the DCC / DCM solution was completed, the ice bath was removed. 4-dimethylaminopyridine (DMAP) (2.366 g; 0.0193 mole) was added to the reaction vessel using a powder funnel. The reaction mixture was stirred for 72 hours at room temperature under nitrogen. The DCM level was supplemented because it evaporated during the reaction. After 72 hours, the reaction mixture was filtered. The filtrate was washed with 2×100 mL 0.25 M HCl and 1×100 mL deionized (DI) water. The organic phase from the extraction was filtered with activated molecular sieves. The amorphous liquid polymer thus obtained was filtered off by drying for 18 hours. The solvent was removed in vacuo on a rotary evaporator to obtain a liquid polymer product (3DP 6t, wherein "t" indicates thiolation, also referred to herein as polySH polymer). 1 HNMR spectroscopy, rheometer (at a shear rate of 99 s -1 =7690) and gel permeation chromatography (Mn = 1952 Da, PDI = 1.62). The following table summarizes other thiolated 3DP compounds using n-acetylcysteine (NAC), thiolactic acid (TLA) and thioglycolic acid (TGA). Each of these was synthesized based on this exemplary synthetic procedure.
[0230] Table 5: Properties of thiolated 3DP polymers
[0231]
[0232] Example 4
[0233] Preparation of Thiolated Compounds of the Disclosure Generally Described by the Formula PolySH
[0234] The polymer with hydroxyl groups can be terminated with carboxylic acid groups replacing the hydroxyl groups. Then, depending on the functional unit of the substituent used for bonding, the carboxylic acid group can be replaced by a thiol-containing moiety via an amide or ester bond. For example, the hydroxyl end groups of a 3DP precursor polymer (see, e.g., Table 1) can be reacted with succinic anhydride to form a succinate-esterified intermediate (3DP-SA), which in turn can react with the amine groups present in cysteine to provide a product with a terminal free thiol group (3DP 6-SA-Cys), which provides an exemplary polySH compound of the present disclosure. This example illustrates this approach.
[0235] Part 1 - Formation of 3DP 6-SA: A 250 mL 3-neck round bottom flask was charged with 3DP 6 (48.9 g; 0.0633 mole, Table 1). The system was placed under vacuum (<0.5 torr) at 40°C for 18 hours to dry the prepolymer. After 18 hours, the system was purged with nitrogen and succinic anhydride (19.0 g; 0.1900 mole) was added to the reaction vessel. The reaction mixture was stirred at 120°C at 50 rpm for 24 hours. The polymer thus obtained was cooled to room temperature and the volatiles were removed on a rotary evaporator to remove residual monomers, which was carried out at room temperature for 18 hours and at 110°C for another 24 hours. Using 1 H NMR was used to confirm the structure of the resulting transparent amorphous polymer product.
[0236] Part 2 - Formation of 3DP 6-SA-Cys: 3DP 6-SA (10.1 g; 0.0093 mole), L-cysteine (3.39 g; 0.0280 mole) and dichloromethane (DCM) (30 mL) were loaded into a 100 mL 2-neck flask. The reactant was stirred at 200 rpm under a nitrogen atmosphere. Separately, N'-dicyclohexylcarbodiimide (DCC) (6.35 g, 0.0307 mole) was dissolved in 10 mL DCM. An ice bath was placed around the reaction vessel, and the DCC / DCM solution was added dropwise. The ice bath was removed after the addition of the DCC / DCM solution was completed, and the reactant was stirred at room temperature for 72 hours under a nitrogen atmosphere. After 72 hours, the reaction mixture was diluted with 50 mL DCM and suction filtered. The filtrate was washed with 2 × 50 mL 0.25 M HCl and 1 × 50 mL DI water. The organic phase from the extraction was filtered through an activated molecular sieve The mixture was dried for 18 hours and then filtered. The solvent was removed in vacuo on a rotary evaporator to provide a waxy polymer product (3DP 6-SA-Cys) with the structure 1 H NMR spectroscopy confirmed.
[0237] Example 5
[0238] Single polymer network from polyEU and polySH
[0239] Thiol-terminated 3DP polymer was mixed with methacrylated 3DP polymer in two different ratios. TPO-L photoinitiator was added to each combination at a concentration of 0.5% (w / w) and the formulations were mixed on a Flacktek high speed mixer at 2000 rpm for 2 minutes followed by 3000 rpm for 3 minutes. The formulations were cured into films having a thickness of 0.75 mm. The films were cut into specimens of 75 mm x 7.5 mm x 0.75 mm and subjected to accelerated degradation at 50°C in phosphate buffer at pH 7.4. Figure 1 In FIG, the degradation curves of 50:50 and 25:75 3DP 6tTLA / 3DP 10m films are shown. Figure 1 The information in shows the effect of water swelling on the polyEU / polySH single polymer network.
[0240] Example 6
[0241] Preparation of isocyanate-terminated compounds of exemplary polymers of the present disclosure of formula PolyΔ
[0242] As mentioned in Example 1, hydroxyl terminated polymers can provide precursor compounds for the polyΔ compounds of the present disclosure. Hydroxyl groups can be converted to thermally reactive groups, such as isocyanate groups as shown in this example, which illustrates diisocyanate capping of 3DP 10.
[0243] A 250 mL 3-neck round bottom flask equipped with a mechanical stirrer and an addition funnel was charged with 3DP 10 (76.7 g; 0.0996 mole). 3DP 10 was dried at 40° C. for 3 days under reduced pressure. After drying, the flask was purged with dry nitrogen and stirring was started at 220 rpm. 15 ml of anhydrous toluene and hexamethylene diisocyanate (HMDI; 33.5 ml; 0.209 mole) were charged to the flask. The reaction mixture temperature was raised to 80° C. for 2 hours and then allowed to return to room temperature. The polymer mixture was then transferred to a single-necked flask and placed on a rotary evaporator. Residual toluene and HMDI were removed under reduced pressure on the rotary evaporator. The non-crystalline liquid polymer thus obtained was purified by H 1 Characterization by NMR spectroscopy (polymer - 70.3 wt. % isocyanate - 29.6 wt. %).
[0244] Example 7
[0245] Dual polymer network from polyEU and polyΔ1+polyΔ2
[0246] A double network film was prepared using a photopolymerized methacrylate polymer network and a thermally cured interpenetrating polymer network. 3DP 12m and 3DP 6 precursor polymers (an exemplary polyΔ1) were mixed in a ratio of 50:50 or 70:30. TPO-L photoinitiator was added to the mixture at a concentration of 0.5% (w / w) relative to the weight of the methacrylated polymer. Hexamethylene diisocyanate (an exemplary polyΔ2) was added to the mixture at 45% of the molar number of hydroxyl groups in the precursor polymer (OH: polymer was 3:1 in the case of 3DP6 (a triaxial polymer)). The formulation was mixed at 2000 rpm for 2 minutes using a Flacktek high-speed mixer and then at 3000 rpm for 2 minutes. The formulation was then cured to a film of 0.75 mm thickness under UV light with an intensity of 30 mW / cm2 for 10 minutes. The photocured film was further thermally cured at 100°C for 1 hour.
[0247] The films were cut into test strips of 75 mm x 7.5 mm x 0.75 mm and subjected to accelerated degradation at 50°C in phosphate buffer at pH 7.4. At different time points during this study, the material was analyzed for mass loss, water content and mechanical properties. The results are shown in Figure 2 .exist Figure 2 In Figure 1, the data show the water swelling behavior for a polyurethane and methacrylated polyester dual network. The addition of the urethane network increases the water swelling up to 25-30% mass loss. After 25-30% mass loss, both 50:50 3DP12m:3DP 6U and 3DP6u show significantly less swelling.
[0248] Example 8
[0249] Mechanics of Poly(SH) and Poly(EU) Materials
[0250] To evaluate the performance of crosslinked 3DP polymer blends, tensile specimens were prepared for mechanical testing. For any particular polymer blend, thiol-terminated 3DP polymers were mixed with one or more methacrylated 3DP polymers (3DPX M) in weight ratios of 25:75 and 50:50, wherein the thiolated polymers were synthesized using thiol lactic acid (3DPXTLA), N-acetyl-L-cysteine (3DPX NAC), or thioglycolic acid (3DPX TGA) as described in Example 3. In addition to the methacrylated 3DP polymers, select blends in similar proportions were studied with a diluent component of polyethylene glycol diacrylate (PEGDA). Photoinitiator (2,4,6-trimethylbenzoyl) phenyl phosphinate (TPOL) was added at 0.5% (w / w) and the blends were mixed on a FlackTek high speed mixer at 2000 revolutions per minute (rpm) for two minutes and then at 3000 rpm for three minutes.
[0251] Each liquid polymer blend was poured between two UV transparent acrylic sheets with a spacing of 0.75 mm and cured under a 100 W UV Blak-Ray lamp for 10 minutes. The cross-linked film was taken out and cut into tensile specimens of size 0.75 x 7.5 x 75 mm. The film strips were mechanically tested on an MTS test frame to evaluate their tensile properties, with at least four film strips for each blend tested. The test parameters for the tensile test are provided in Table 6. The polymer blends studied and their corresponding tensile properties are reported in Table 7.
[0252] Table 6: Test parameters
[0253]
[0254] Table 7: Photopolymerization tensile mechanics of Poly(SH) and Poly(EU)
[0255]
[0256] Example 9
[0257] Stability of Poly(SH) and Poly(EU) Combinations
[0258] Part 1 - Premature crosslinking of polymer blends with and without stabilizers was investigated. Thiol-terminated photoreactive compounds were mixed with methacrylated photoreactive compounds in a 50:50 ratio. The intended stabilizing compounds were added to aliquots of the reactive mixture at different concentrations. Each formulation mixture was mixed on a FlakTek high-speed mixer at 2000 revolutions per minute (rpm) for two minutes and then at 3000 rpm for three minutes. An aliquot of each mixture was transferred to a Petri dish and stored at room temperature (RT) or 50°C. The stability of the polymer blends was qualitatively evaluated by the solidification of the blends and the results are reported in Table 8.
[0259]
[0260] Part 2 - A thiol-terminated polymer (3DP 19t TGA) was mixed with a methacrylated polymer (3DP20m) in a 50:50 weight ratio. The selected stabilizers were added separately to aliquots of the liquid polymer blends and the viscosity of the formulations was evaluated by rheometer (25°C, at a shear rate of 100 s-1) at 24 hours to obtain a quantitative measure of stability. The initial viscosity of the resin without stabilizer was 3920 ± 20 cP. The viscosity of the stabilized polymer blends stored at room temperature for 24 hours is provided in Table 9.
[0261] Table 9: Viscosity of stabilized 3DP 19t TGA and 3DP 20m blends after 24 hours storage
[0262]
[0263] All references disclosed herein, including patent references and non-patent references, are incorporated by reference in their entirety, as if each reference were incorporated individually.
[0264] It should be understood that the terms used herein are for the purpose of describing specific embodiments only and are not intended to be limiting. It should also be understood that unless specifically defined herein, the terms used herein refer to their conventional meanings known in the relevant art.
[0265] References throughout this specification to "one embodiment" or "an embodiment" and variations thereof mean that the particular features, structures, or characteristics described in connection with the embodiment are included in at least one embodiment. Thus, appearances of the phrases "in one embodiment" or "in an embodiment" in multiple places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, in one or more embodiments, the particular features, structures, or characteristics may be combined in any suitable manner.
[0266] As used in this specification and the appended claims, the singular forms "a", "an", and "the" include plural references, i.e., one or more, unless the context and the context clearly indicate otherwise. It should also be noted that, unless the context and the context clearly indicate inclusiveness or exclusiveness as appropriate, the conjunctions "and" and "or" are generally used to include "and / or" in the broadest sense. Therefore, the use of alternatives (such as "or") should be understood to mean one, both, or any combination of the alternatives. In addition, the composition of "and" and "or" when referred to as "and / or" in this article is intended to cover embodiments including all related projects or concepts and one or more other alternative embodiments including less than all related projects or concepts.
[0267] Throughout the specification and the appended claims, unless the context requires otherwise, the words "comprise" and its synonyms and variations such as "have" and "include", and variations thereof such as "include" and "comprising" are to be interpreted in an open inclusive sense, for example, "including but not limited to". The term "consisting essentially of limits the scope of a claim to the specified materials or steps, or to those materials or steps that do not materially affect the basic and novel characteristics of the claimed disclosure. In the event of a conflict, the present specification, including interpretation of terms, will control. In addition, all materials, methods, and examples are illustrative and not intended to be limiting.
[0268] Any title used in this article is only used to allow readers to quickly complete the reading and should not be interpreted in any way as a limitation of the present disclosure or claims. Therefore, the title and abstract of the disclosure provided herein are only for convenience and do not explain the scope or meaning of the embodiment.
[0269] Where numerical ranges are provided herein, it is to be understood that, unless the context clearly indicates otherwise, each intermediate value (to one tenth of the unit of the lower limit) between the upper and lower limits of the range and any other stated or intermediate values within the stated range is encompassed within the disclosure. The upper and lower limits of these smaller ranges may be independently included within the smaller ranges (which are also encompassed within the disclosure), subject to any explicitly excluded limits within the stated ranges. Where the stated range includes one or two limits, ranges excluding one or both of those included limits are also encompassed within the disclosure.
[0270] For example, unless otherwise indicated, any concentration range, percentage range, ratio range, or integer range provided herein should be understood to include the value of any integer within the range, and fractions thereof (such as tenths and hundredths of integers) where appropriate. Similarly, unless otherwise indicated, any numerical range described herein involving any physical feature, such as polymer subunits, size, or thickness, should be understood to include any integer within the described range. As used herein, unless otherwise indicated, the term "about" means ±20% of the indicated range, value, or structure.
[0271] All U.S. patents, U.S. patent application disclosures, U.S. patent applications, foreign patents, foreign patent applications, and non-patent publications mentioned in this specification and / or listed in the application data sheet are incorporated herein by reference in their entirety. For the purpose of describing and disclosing materials and methods such as described in publications, such documents may be incorporated by reference, which may be used in conjunction with the disclosures currently described. The publications discussed above and throughout the text are provided only for their disclosures prior to the filing date of this application. Nothing herein should be construed as admitting that the inventor has no right to predate any reference publication by virtue of prior disclosures.
[0272] All patents, publications, scientific articles, websites, and other documents and materials cited or mentioned herein are indicative of the technical level of those skilled in the art to which the present disclosure belongs, and each such cited document and material is incorporated herein by reference to the same extent as if it had been individually incorporated by reference in its entirety or presented herein in its entirety. Applicants reserve the right to physically incorporate into this specification any and all materials and information from any such patents, publications, scientific articles, websites, electronically accessible information, and other reference materials or documents.
[0273] In general, in the following claims, the terms used should not be construed to limit the claims to the specific embodiments disclosed in the specification and the claims, but should be construed to include all possible embodiments and the full scope of equivalents to which such claims are entitled. Therefore, the claims are not limited by the disclosure.
[0274] In addition, the written description portion of this patent includes all claims. In addition, all claims, including all original claims and all claims from any and all priority documents, are incorporated by reference in their entirety into the written description portion of the specification, and applicant reserves the right to physically incorporate any and all such claims into the written description or any other portion of this application. Thus, for example, in no event can this patent be construed as asserting that a written description of a claim is not provided without the exact wording of the claim being set forth below in the written description portion of this patent.
[0275] The claims will be construed as required by law. However, and notwithstanding any assertion or feeling of ease or difficulty in construing any claim or any portion thereof, in no event shall any adjustment or modification of the claims or any portion thereof during the proceedings relating to the application(s) becoming this patent be construed as a loss of rights to anything that does not form part of the prior art and all equivalents.
[0276] Other non-limiting embodiments are within the scope of the following claims.This patent should not be construed as limited to the specific examples or non-limiting embodiments or methods specifically and / or expressly disclosed herein.
Claims
1. A composition comprising: a first organic compound (polySH) which has a plurality of thiol groups (SH) and is biodegradable under physiological conditions, a second organic polymeric compound (polyEU) having a plurality of ethylenically unsaturated groups (EU), having a molecular weight greater than 1000 g / mol and being biodegradable under physiological conditions, Photoinitiators, and Stabilizers, The total concentration of the initiator is less than 1.0 wt %.
2. The composition of claim 1, having an equivalent ratio of SH to EU of X:Y, wherein X is in the range of 25-75, Y is in the range of 75-25, and the sum of X and Y is 100.
3. The composition of claim 1, wherein polySH is water soluble. The composition according to claim 1 , wherein polySH is a macromonomer.
5. The composition of claim 1, wherein polySH is a macromonomer having a molecular weight greater than 1,000 g / mol.
6. The composition of claim 1, wherein the molecular weight of polySH is less than 500 g / mol.
7. The composition of claim 1, wherein polyEU is water soluble.
8. The composition of claim 1, wherein EU of PolyEU is acrylate.
9. The composition of claim 1, wherein EU of PolyEU is methacrylate.
10. The composition of claim 1, wherein EU of PolyEU is norbornene.
11. The composition of claim 1, wherein polyEU is a macromonomer.
12. The composition of claim 1, wherein at least one of polySH and polyEU further has multiple carbonyl groups, wherein optionally polyEU has multiple carbonyl groups, or wherein optionally polySH and polyEU each have multiple carbonyl groups.
13. The composition of claim 1, wherein at least one of polySH and polyEU further has a plurality of ester groups, wherein optionally polyEU has a plurality of ester groups, or wherein optionally polySH and polyEU each have a plurality of ester groups.
14. The composition of claim 1 , wherein at least one of polyEU and polySH further has a plurality of ester groups and a plurality of carbonate groups, wherein optionally polyEU simultaneously has a plurality of ester groups and a plurality of carbonate groups, or wherein optionally both polySH and polyEU simultaneously have a plurality of ester groups and a plurality of carbonate groups.
15. The composition of claim 1, wherein at least one of polySH and polyEU further has a plurality of ester groups and a plurality of urethane groups, wherein optionally polyEU simultaneously has a plurality of ester groups and a plurality of urethane groups, or wherein optionally both polySH and polyEU simultaneously have a plurality of ester groups and a plurality of urethane groups.
16. The composition of claim 1, wherein at least one of polySH and polyEU further has a plurality of carbonate groups and a plurality of urethane groups, wherein optionally polyEU simultaneously has a plurality of carbonate groups and a plurality of urethane groups, or wherein optionally both polySH and polyEU simultaneously have a plurality of carbonate groups and a plurality of urethane groups.
17. The composition according to claim 1, wherein the plurality of SH of polySH is selected from 2, 3 and 4.
18. The composition of claim 1, wherein the plurality of EUs of PolyEU is selected from 2, 3, and 4.
19. The composition of claim 1, which does not contain volatile materials having a boiling point below 110°C.
20. The composition of claim 1 which is anhydrous.
21. The composition of claim 1, which is fluid at room temperature of about 18°C to about 22°C.
22. A composition comprising a photochemically cured reaction product of the composition according to any one of claims 1 to 21.
23. The composition of claim 22, which is biodegradable under physiological conditions.
24. The composition of claim 22, which is solid at 50°C.
25. An additive manufacturing method, the additive manufacturing method comprising: (a) providing a barrel containing a first composition according to any one of claims 1 to 21; (b) directing actinic radiation from a light source into the first composition in the vat, wherein the actinic radiation is effective to induce polymerization of components of the composition to form a second composition; and (c) forming a solid article comprising the second composition.
Citation Information
Patent Citations
Medical implants and anti-scarring agents
US20050149158A1
Medical implants and fibrosis-inducing agents
US20060240063A9
Aerodynamically efficient freight truck and trailer
US20160059910A1
Medicament injection device
US20200054839A1
